Anxiety disorders, excluding more controls

KRA_PSY_ANXIETY_EXMORE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F40-F48 Hospital discharge: ICD-9 — 300[0-3\|6-9]\|3078A\|309 Hospital discharge: ICD-8 — 300[0-2]\|30030\|300[5-9]\|305\|30680\|30799 Cause of death: ICD-10 — F40-F48 Cause of death: ICD-9 — 300[0-3\|6-9]\|3078A\|309 Cause of death: ICD-8 — 300[0-2]\|30030\|300[5-9]\|305\|30680\|30799 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints None	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: KRA_PSY_ANYMENTAL

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	KRA_PSY_ANXIETY_EXMORE
CONTROL_EXCLUDE	KRA_PSY_ANYMENTAL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F4
HD_ICD_9	300[0-3\|6-9]\|3078A\|309
HD_ICD_8	300[0-2]\|30030\|300[5-9]\|305\|30680\|30799
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F4
COD_ICD_9	300[0-3\|6-9]\|3078A\|309
COD_ICD_8	300[0-2]\|30030\|300[5-9]\|305\|30680\|30799
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Anxiety disorders, excluding more controls based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	534702	319646	211486
Only index persons	494695	301970	192725
Unadjusted period prevalence (%)
Whole population	7.84	9.16	5.91
Only index persons	9.64	11.10	7.36
Median age at first event (years)
Whole population	31.24	32.68	28.98
Only index persons	30.42	31.83	28.21

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	59087	41096	17991
Unadjusted period prevalence (%)	12.65	14.58	8.24
Median age at first event (years)	37.08	36.48	38.47

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
51802: Matched controls
336908

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F20

ICD-10 Finland

Schizophrenia

1180.4

322.3

373

F50.8

ICD-10 Finland

Other eating disorders

36.4

322.1

284

IHZ07, ,

SPAT

14.1

321.1

385

179

IGY99, ,

SPAT

4.6

320.5

906

1306

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

319.0

4757

16971

SFA30

NOMESCO Finland

Three-surface restoration

1.5

318.6

19364

98044

N05AC01

ATC

periciazine; systemic

29.7

315.2

291

F10.01

ICD-10 Finland

Alcohol-related acute intoxication with permanent or other somatic damage

42.9

314.9

269

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.5

312.9

12284

56868

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

80.0

312.3

245

F60.0

ICD-10 Finland

Paranoid personality disorder

403.3

312.1

370

RS220, ,

NOMESCO Finland

5.8

312.0

683

770

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.2

310.1

2986

9041

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

14.5

310.0

367

166

IAA02

NOMESCO Finland

Consultation concerning further psychiatric treatment

58.8

309.9

252

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

53.8

309.7

255

F20.0

ICD-10 Finland

Paranoid schizophrenia

2289.1

309.6

356

N05AX13

ATC

paliperidone; systemic

+∞

308.5

352

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.0

308.4

3679

12123

E66.8

ICD-10 Finland

Other obesity

2.6

307.7

2834

7396

N03AG01

ATC

valproic acid; systemic, rectal

12.2

307.7

5039

2960

IBA03

NOMESCO Finland

Psychotherapy evaluation

347.8

307.7

945

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

7.2

307.7

1134

1047

P27

ICPC

Fear of mental disorder

11.8

307.7

924

517

F61.0

ICD-10 Finland

Mixed personality disorders

191.9

307.7

2150

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

51.6

307.7

5440

764

F39

ICD-10 Finland

Unspecified mood [affective] disorder

33.6

307.7

1792

359

SPAT1307

SPAT

Psychosocial counselling and guidance

5.2

307.7

4841

6609

P29

ICPC

Psychological sympt/compl other

7.9

307.7

6335

5854

K04.08

ICD-10 Finland

Other specified pulpit

2.1

307.7

3868

12458

ZXY82

NOMESCO Finland

Nurse in multidisciplinary team

2453.9

307.7

381

F90.0

ICD-10 Finland

Disturbance of activity and attention

12.1

307.7

2972

1682

R74

ICPC

Upper respiratory infection acute

1.8

307.7

17680

75214

F45.8

ICD-10 Finland

Other somatoform disorders

4.3

307.7

5828

9668

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

+∞

307.7

396

F03

ICD-10 Finland

Unspecified dementia

6.7

307.7

676

660

P98

ICPC

Psychosis NOS/other

217.1

307.7

496

A29

ICPC

General symptom/complaint other

1.9

307.7

5173

18818

N06AX03

ATC

mianserin; oral

10.4

307.7

3725

2491

F60.5

ICD-10 Finland

Anankastic personality disorder

31.6

307.7

1047

220

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

192.2

307.7

2071

SPAT1265

SPAT

Breathalyser

15.0

307.7

591

259

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

307.7

12515

53783

2989X

ICD-9 Finland

Other nonorganic psychoses, Unspecified psychosis

+∞

307.7

476

N06AG02

ATC

moclobemide; oral

8.4

307.7

3235

2639

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

307.7

15406

73519

SPAT1241

SPAT

Extensive assessment of psychosocial situation

9.5

307.7

830

577

R56.8

ICD-10 Finland

Other and unspecified convulsions

4.2

307.7

2774

4433

N06AX26

ATC

vortioxetine; oral

9.3

307.7

6873

5425

L02

ICPC

Back symptom/complaint

2.2

307.7

5230

16433

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

127.3

307.7

292

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.7

307.7

12210

52623

P99

ICPC

Psychological disorders other

21.7

307.7

2721

860

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

307.7

11041

43203

F50.9

ICD-10 Finland

Eating disorder, unspecified

54.4

307.7

751

ZY000

NOMESCO Finland

Hospital inpatient

52.5

307.7

1229

156

F60.9

ICD-10 Finland

Personality disorder, unspecified

310.5

307.7

1619

IER01

NOMESCO Finland

Psychoeducation, group

1327.0

307.7

624

J01DB01

ATC

cefalexin; oral

1.7

307.7

41358

236572

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

35.8

307.7

377

P01AB01

ATC

metronidazole; oral, rectal

1.7

307.7

19689

89888

G43.9

ICD-10 Finland

Migraine, unspecified

2.8

307.7

3568

8688

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

1168.3

307.7

734

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

4004.4

307.7

615

F51.0

ICD-10 Finland

Nonorganic insomnia

3.6

307.7

11195

24032

M54.4

ICD-10 Finland

Lumbago with sciatica

2.0

307.7

9048

32975

N05AX12

ATC

aripiprazole; systemic

212.0

307.7

4606

155

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.1

307.7

13307

47785

F29

ICD-10 Finland

Unspecified nonorganic psychosis

435.3

307.7

3612

SAA03

NOMESCO Finland

Extended examination of mouth

1.6

307.7

19706

94334

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.1

307.7

4716

15125

Z72.1

ICD-10 Finland

Alcohol use

11.6

307.7

734

418

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.2

307.7

6301

19816

SPAT1389

SPAT

Visit based on need for special support

3.8

307.7

1224

2111

F41.08

ICD-10 Finland

Mild or other specified panic syndrome

23.1

307.7

422

120

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

2.6

307.7

2257

5758

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

6701.9

307.7

1017

SPAT1216

SPAT

Assessment of functional ability

1.9

307.7

5809

20532

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.6

307.7

13127

57831

F41.1

ICD-10 Finland

Generalized anxiety disorder

23.2

307.7

8039

2652

U02

ICPC

Urinary frequency/urgency

1.8

307.7

6219

24038

A28

ICPC

Limited function/disability NOS

2.1

307.7

5846

19298

R06AE07

ATC

cetirizine; oral

1.5

307.7

21790

107860

F05.9

ICD-10 Finland

Delirium, unspecified

6.3

307.7

733

761

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

14.6

307.7

6391

3213

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

69.4

307.7

2596

256

N06AA10

ATC

nortriptyline; systemic

4.3

307.7

1127

1745

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

3.3

307.7

2314

4682

N05AN01

ATC

lithium; oral

97.5

307.7

2224

155

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.7

307.7

13136

55714

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

1205.3

307.7

2970

N06AB05

ATC

paroxetine; oral

8.8

307.7

5601

4597

J01FF01

ATC

clindamycin; systemic

1.6

307.7

12353

55032

R52.9

ICD-10 Finland

Pain, unspecified

2.4

307.7

5166

15141

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

7.7

307.7

641

548

F32

ICD-10 Finland

Depressive episode

7.0

307.7

4365

4378

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.2

307.7

3160

6720

TAB00

NOMESCO Finland

Lumbar puncture

2.8

307.7

2059

4983

N05AH02

ATC

clozapine; systemic

1582.5

307.7

1459

F33.8

ICD-10 Finland

Other recurrent depressive disorders

45.2

307.7

815

119

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.9

307.7

16075

64220

30088

ICD-8 Finland

Neuroses, Other

+∞

307.7

610

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

615.5

307.7

3280

K59.0

ICD-10 Finland

Constipation

2.8

307.7

2576

6179

SPAT1235

SPAT

Mental health, emotional support

11.5

307.7

431

245

K59.09

ICD-10 Finland

Constipation, unspecified

2.9

307.7

3072

7278

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

34.1

307.7

2751

554

F43.0

ICD-10 Finland

Acute stress reaction

2.9

307.7

3337

7904

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

121.7

307.7

3720

214

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.3

307.7

21430

79119

ZXY49

NOMESCO Finland

Other health care provider

1378.1

307.7

433

S06.0

ICD-10 Finland

Concussion

2.6

307.7

5763

15285

N05AF05

ATC

zuclopenthixol; systemic

329.5

307.7

601

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

977.7

307.7

731

N06AX17

ATC

milnacipran; oral

13.2

307.7

756

379

N06AX11

ATC

mirtazapine; oral

5.7

307.7

26343

51837

IFA99

NOMESCO Finland

Other psychiatric pharmacotherapy service

+∞

307.7

520

S29

ICPC

Skin symptom/complaint other

1.7

307.7

8431

34691

N06CA01

ATC

amitriptyline and psycholeptics; systemic

3.7

307.7

6272

12072

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.8

307.7

21560

96682

D06

ICPC

Abdominal pain localized other

2.1

307.7

4240

13778

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

226.9

307.7

824

F43.25

ICD-10 Finland

Adaptive disorder with mixed mental disorder and behavioral disorder

40.3

307.7

357

C07AA05

ATC

propranolol; systemic

3.7

307.7

15071

33518

R06.0

ICD-10 Finland

Dyspnoea

2.0

307.7

12756

47901

M79.1

ICD-10 Finland

Myalgia

2.1

307.7

7780

25806

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.7

307.7

2362

5772

SPAT1263

SPAT

Sampling

1.5

307.7

19730

95825

F10.09

ICD-10 Finland

Alcohol intoxication UNS

159.2

307.7

1405

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.0

307.7

4784

11007

A05

ICPC

Feeling ill

2.5

307.7

3416

9161

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.5

307.7

4096

11388

F41

ICD-10 Finland

Other anxiety disorders

6.4

307.7

1271

1322

R1220

NOMESCO Finland

Psychological examination of need and possibilities to rehabilitation

14.0

307.7

674

318

X59

ICD-10 Finland

Exposure to unspecified factor

1.8

307.7

9227

35652

N03AX09

ATC

lamotrigine; oral

20.1

307.7

5207

1861

N17

ICPC

Vertigo/dizziness

2.0

307.7

5298

18192

N06AA06

ATC

trimipramine; systemic

9.0

307.7

1650

1233

R13

ICD-10 Finland

Dysphagia

2.3

307.7

2929

8531

R20.2

ICD-10 Finland

Paraesthesia of skin

2.2

307.7

3540

10829

N05AX08

ATC

risperidone; systemic

29.7

307.7

6384

1585

F32.9

ICD-10 Finland

Depressive episode, unspecified

23.2

307.7

15108

5881

P25

ICPC

Phase of life problem adult

3.6

307.7

2665

5044

R52.1

ICD-10 Finland

Chronic intractable pain

7.6

307.7

590

509

N05BE01

ATC

buspirone; oral

23.2

307.7

3116

926

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

16.8

307.7

1179

467

F33

ICD-10 Finland

Recurrent depressive disorder

11.7

307.7

1835

1056

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

13.7

307.7

13500

8470

G40.9

ICD-10 Finland

Epilepsy, unspecified

3.8

307.7

1516

2650

K02.1

ICD-10 Finland

Caries of dentine

1.8

307.7

31245

155060

SPAT1301

SPAT

No procedures

1.7

307.7

14055

61870

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

307.7

18351

88525

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

+∞

307.7

500

N05BA01

ATC

diazepam; systemic, rectal

5.9

307.7

10294

13504

SGA01

NOMESCO Finland

Emergency treatment

1.7

307.7

8054

32796

SPAT1246

SPAT

Screening of depression or other psychiatric problem

2.9

307.7

2347

5460

-1, ,

NOMESCO Finland

1.6

307.7

16806

76710

30799

ICD-8 Finland

Transient situational disturbances

+∞

307.7

385

IGY02

NOMESCO Finland

Psychiatric monitoring contact

98.3

307.7

3153

222

J02AC01

ATC

fluconazole; systemic

1.6

307.7

19514

92152

30040

ICD-8 Finland

Neuroses, Neurotico-depressiva

+∞

307.7

370

F31.8

ICD-10 Finland

Other bipolar affective disorders

192.4

307.7

1909

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

307.7

6490

22287

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

307.7

8916

33315

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

248.8

307.7

455

Z01.2

ICD-10 Finland

Dental examination

1.5

307.7

22770

114462

F32.1

ICD-10 Finland

Moderate depressive episode

8.1

307.7

4985

4357

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

39.0

307.7

2947

520

N06AB06

ATC

sertraline; oral

10.8

307.7

11845

9011

L12

ICPC

Hand/finger symptom/complaint

1.8

307.7

7721

29642

C07AB07

ATC

bisoprolol; oral

1.5

307.7

19242

95539

SPAT1310

SPAT

Counselling related to known health issue

1.6

307.7

14600

66665

IGV01

NOMESCO Finland

Psychiatric network contact

1473.0

307.7

916

P73

ICPC

Affective psychosis

117.8

307.7

324

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

105.1

307.7

623

R06.4

ICD-10 Finland

Hyperventilation

5.0

307.7

999

1314

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

307.7

13866

52755

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.9

307.7

5691

20742

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

229.1

307.7

523

M03BX02

ATC

tizanidine; oral

1.6

307.7

30981

164039

N02BE01

ATC

paracetamol; systemic, rectal

1.9

307.7

44176

254871

R51.80

ICD-10 Finland

Headache

2.7

307.7

9832

26644

SFA10

NOMESCO Finland

One-surface restoration

1.6

307.7

28046

141391

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

335.8

307.7

763

R00.2

ICD-10 Finland

Palpitations

2.2

307.7

3967

12362

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

18.3

307.7

3916

1498

K10.3

ICD-10 Finland

Alveolitis of jaws

2.5

307.7

2465

6674

X78

ICD-10 Finland

Intentional self-harm by sharp object

3200.8

307.7

494

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.7

307.7

3363

8544

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.4

307.7

4755

13546

N06AA09

ATC

amitriptyline; systemic

3.9

307.7

5791

10511

A02BC02

ATC

pantoprazole; systemic

1.9

307.7

33754

167204

F41.00

ICD-10 Finland

Moderate panic disorder

111.7

307.7

2471

151

Z63.0

ICD-10 Finland

Problems in relationship with spouse or partner

14.0

307.7

613

288

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

56.7

307.7

764

ZYB04

NOMESCO Finland

Outreach service in patient’s home or everyday environment

334.3

307.7

409

P18

ICPC

Medication abuse

60.4

307.7

579

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

135.8

307.7

741

N06AB03

ATC

fluoxetine; oral

7.6

307.7

10727

11259

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.6

307.7

2601

6838

IEV99

NOMESCO Finland

Other psychiatric network intervention

1526.8

307.7

478

N02AX02

ATC

tramadol; systemic, rectal

1.9

307.7

21108

91270

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

84.3

307.7

450

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

7.2

307.7

4884

4787

SFA20

NOMESCO Finland

Two-surface restoration

1.6

307.7

29588

154319

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

509.5

307.7

1447

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.1

307.7

9253

32210

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

39.8

307.7

5269

955

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

142.0

307.7

583

N06AX21

ATC

duloxetine; oral

6.3

307.7

10008

12363

F43.29

ICD-10 Finland

Adaptation disorder UNS

15.2

307.7

2812

1267

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

307.7

4098

13426

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

307.7

26235

130979

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

3.2

307.7

1848

3889

F61

ICD-10 Finland

Mixed and other personality disorders

73.7

307.7

494

V03AA01, ,

ATC

12.0

307.7

884

487

N06AX12

ATC

bupropion; oral

12.5

307.7

7398

4448

3090A

ICD-9 Finland

Adjustment reaction, Brief depressive reaction

+∞

307.7

524

A04

ICPC

Weakness/tiredness general

2.6

307.7

7991

22321

SAA01

NOMESCO Finland

Simple examination of mouth

1.9

307.7

38199

199066

F34.1

ICD-10 Finland

Dysthymia

39.1

307.7

4072

733

N05CD07

ATC

temazepam; oral

4.9

307.7

6967

10275

F10.24

ICD-10 Finland

Alcohol depence active use

71.3

307.7

1137

106

WX290

NOMESCO Finland

Other blockage of nerve

1.8

307.7

25285

117807

N03AF02

ATC

oxcarbazepine; oral

3.6

307.7

1687

3087

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

3.5

307.7

4707

9418

N05AA02

ATC

levomepromazine; systemic

42.8

307.7

3817

625

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

69.4

307.7

8425

940

F45.9

ICD-10 Finland

Somatoform disorder, unspecified

44.4

307.7

359

A02BC03

ATC

lansoprazole; oral

1.7

307.7

12843

54562

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

307.7

12380

53607

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

145.4

307.7

3793

183

A03

ICPC

Fever

1.8

307.7

8650

34276

F10.22

ICD-10 Finland

Alcohol dependence is currently on clinically controlled discontinuation medication

81.9

307.7

263

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

7.9

307.7

1187

995

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.8

307.7

5742

21290

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

20.8

307.7

733

232

R4110

NOMESCO Finland

Physiotherapy

1.6

307.7

12124

53533

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

6.3

307.7

3872

4267

N06AA04

ATC

clomipramine; systemic

14.2

307.7

1460

687

G44.2

ICD-10 Finland

Tension-type headache

2.5

307.7

8082

23497

F40.2

ICD-10 Finland

Specific (isolated) phobias

22.6

307.7

816

238

N04AA02

ATC

biperiden; systemic

44.0

307.7

1338

203

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

+∞

307.7

512

E0000UV, ,

ATC

1.5

307.7

19428

97626

IHZ05, ,

SPAT

5.1

307.7

2671

3583

Z91.5

ICD-10 Finland

Personal history of self-harm

150.9

307.7

277

N05AH03

ATC

olanzapine; systemic

65.4

307.7

6963

798

K07.60

ICD-10 Finland

Snapping jaw

2.7

307.7

3021

7425

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

350.2

307.7

1718

P79

ICPC

Phobia/compulsive disorder

14.5

307.7

399

180

A02BC05

ATC

esomeprazole; systemic

1.7

307.7

19670

89884

P74

ICPC

Anxiety disorder/anxiety state

13.4

307.7

4750

2511

P15

ICPC

Chronic alcohol abuse

15.4

307.7

2125

934

F41.01

ICD-10 Finland

Severe panic disorder

151.1

307.7

778

A06AC01

ATC

ispaghula (psylla seeds); oral

1.9

307.7

12164

47601

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

307.7

6259

23896

Z2446

NOMESCO Finland

Social worker

6.1

307.7

4809

5559

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

14.2

307.7

2881

1390

F40.8

ICD-10 Finland

Other phobic anxiety disorders

22.4

307.7

427

125

Z3226

NOMESCO Finland

Physiotherapist

2.0

307.7

8613

30238

F40.01

ICD-10 Finland

Agoraphobia with concomitant panic disorder

108.1

307.7

850

R1250

NOMESCO Finland

Evaluation of functional capability

4.2

307.7

1127

1780

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.3

307.7

4061

8353

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

307.7

8680

32615

ZY010

NOMESCO Finland

Hospital outpatient

13.6

307.7

5155

2709

W0A12

NOMESCO Finland

Planned therapy visit for psychiatric disease

146.5

307.7

513

H01

ICPC

Ear pain/earache

1.9

307.7

5774

20844

Z72.2

ICD-10 Finland

Drug use

60.9

307.7

473

R53

ICD-10 Finland

Malaise and fatigue

2.6

307.7

13695

40845

N05AH04

ATC

quetiapine; oral

16.5

307.7

19412

11836

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

3592.2

307.7

553

F84.5

ICD-10 Finland

Asperger syndrome

45.0

307.7

480

IGP01

NOMESCO Finland

Psychiatric family contact

85.6

307.7

560

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

45.7

307.7

487

F10.25

ICD-10 Finland

Alcohol dependence continuous use

87.8

307.7

1277

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

4017.7

307.7

617

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

603.3

307.7

2220

F40.1

ICD-10 Finland

Social phobias

34.0

307.7

3652

750

F50.0

ICD-10 Finland

Anorexia nervosa

177.4

307.7

406

2961C

ICD-9 Finland

Affective psychoses, Manic disorder, recurrent episode[VAKAVA MASENNUSTILA,KESKIVAIKEA]

+∞

307.7

374

P16

ICPC

Acute alcohol abuse

15.6

307.7

1124

477

P06

ICPC

Sleep disturbance

3.0

307.7

7355

17595

F43.01

ICD-10 Finland

Acute stress reaction moderate

9.1

307.7

1513

1111

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

6.7

307.7

1054

1046

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

+∞

307.7

397

F43.00

ICD-10 Finland

Acute stress reaction mild

10.0

307.7

2652

1810

F50.1

ICD-10 Finland

Atypical anorexia nervosa

75.0

307.7

355

P19

ICPC

Drug abuse

19.5

307.7

740

250

N06AX16

ATC

venlafaxine; oral

10.6

307.7

14925

12418

N06AX22

ATC

agomelatine; oral

19.1

307.7

2295

816

M79.0

ICD-10 Finland

Rheumatism, unspecified

4.5

307.7

2022

2986

N03AF01

ATC

carbamazepine; oral, rectal

3.7

307.7

2556

4663

R21

ICPC

Throat symptom/complaint

1.9

307.7

12105

45794

N05AX16

ATC

brexpiprazole; oral

162.3

307.7

273

N03AX12

ATC

[U] gabapentin; oral

2.7

307.7

9401

25151

L17

ICPC

Foot/toe symptom/complaint

1.7

307.7

13529

56621

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.4

307.7

3882

11164

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

92.5

307.7

507

F34.0

ICD-10 Finland

Cyclothymia

56.6

307.7

320

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

3.5

307.7

3466

6703

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.0

307.7

5929

20293

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

10.4

307.7

2451

1606

N02BF02

ATC

pregabalin; oral

3.6

307.7

3593

6796

SPAT1283

SPAT

Restricted health certificate

2.0

307.7

10102

36640

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

+∞

307.7

688

L01

ICPC

Neck symptom/complaint

2.0

307.7

7958

28251

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

337.7

307.7

1217

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.6

307.7

3104

8069

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.0

307.7

12123

45533

Z02.7

ICD-10 Finland

Issue of medical certificate

2.5

307.7

3415

9134

WZC00

NOMESCO Finland

Treatment plan or consultation

1.7

307.7

18054

80959

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

131.1

307.7

1753

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

2.3

307.7

3897

11337

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

41.4

307.7

2294

377

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

558.0

307.7

678

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

845.3

307.7

1758

F40.00

ICD-10 Finland

Agoraphobia without concomitant panic disorder

103.0

307.7

393

H02AB06

ATC

prednisolone; systemic

1.5

307.7

21580

108981

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.7

307.7

10309

42237

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

244.5

307.7

1919

R52.2

ICD-10 Finland

Other chronic pain

4.5

307.7

2349

3485

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

+∞

307.7

442

F41.3

ICD-10 Finland

Other mixed anxiety disorders

15.0

307.7

1673

747

WX110

NOMESCO Finland

Infiltration anesthesia

1.8

307.7

36850

193891

R05

ICPC

Cough

1.7

307.7

11607

47731

IEY01

NOMESCO Finland

Psychoeducation, individual

219.5

307.7

732

P01

ICPC

Feeling anxious/nervous/tense

6.2

307.7

11746

15287

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.7

307.7

28661

139627

D01

ICPC

Abdominal pain/cramps general

2.3

307.7

6604

19727

F50.2

ICD-10 Finland

Bulimia nervosa

56.8

307.7

433

IBB03

NOMESCO Finland

Assessment of vocational rehabilitation needs in a mental health context

+∞

307.7

374

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

10.7

307.7

3166

2038

M79.7

ICD-10 Finland

Fibromyalgia

4.9

307.7

2324

3186

N05AB01

ATC

dixyrazine; systemic

20.3

307.7

779

253

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

32.8

307.7

10162

2489

R41.0

ICD-10 Finland

Disorientation, unspecified

4.4

307.7

1009

1503

F10.0

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Acute intoxication

60.9

307.7

427

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

481.8

307.7

874

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

69.5

307.7

7358

801

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

4.3

307.7

3127

4908

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.3

307.7

5860

17989

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

2.1

307.7

3589

11326

F32.0

ICD-10 Finland

Mild depressive episode

4.3

307.7

1539

2392

F10.20

ICD-10 Finland

Alcohol dependence currently independent

89.8

307.7

1800

135

M79.6

ICD-10 Finland

Pain in limb

1.8

307.7

21071

93246

SAA02

NOMESCO Finland

Basic examination of mouth

1.7

307.7

34670

185102

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

8.0

307.7

1251

1035

SPAT1312

SPAT

General health counselling

1.5

307.7

14719

70156

K04.0

ICD-10 Finland

Pulpitis

2.0

307.7

4744

16474

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

5.5

307.7

933

1124

F60.8

ICD-10 Finland

Other specific personality disorders

151.4

307.7

689

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.1

307.7

3811

12220

F31

ICD-10 Finland

Bipolar affective disorder

108.3

307.7

1060

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.6

307.7

21129

103156

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

450.4

307.7

1349

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

10.2

307.7

714

460

ZXD05

NOMESCO Finland

Urgent procedure

1.6

307.7

13671

61935

N05AB03

ATC

perphenazine; systemic, rectal

46.0

307.7

3082

463

N30.0

ICD-10 Finland

Acute cystitis

1.8

307.7

7460

28328

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.7

307.7

14345

62459

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

226.5

307.7

1390

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

80.6

307.7

552

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.8

307.7

3559

8751

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.8

307.7

24747

114422

N05BA12

ATC

alprazolam; oral

6.2

307.7

8522

10296

R02

ICPC

Shortness of breath/dyspnoea

2.2

307.7

6156

19834

AA1AD

NOMESCO Finland

CT of head and brain

2.1

307.7

12105

42074

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

188.9

307.7

2489

M01AE02

ATC

naproxen; oral, rectal

1.5

307.7

27500

146524

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

1083.8

307.7

959

N06AB04

ATC

citalopram; systemic

7.4

307.7

18160

22881

F99

ICD-10 Finland

Mental disorder, not otherwise specified

77.2

307.7

1966

172

30000

ICD-8 Finland

Neuroses, Anxiety neurosis

+∞

307.7

1133

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

10.5

307.7

722

453

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

+∞

307.7

749

T36

ICD-10 Finland

Poisoning by systemic antibiotics

73.4

307.7

4936

483

Z2221

NOMESCO Finland

Medical doctor

1.8

307.7

13431

53985

SPAT1227

SPAT

Substance abuse rehabilitation

18.8

307.7

431

150

SPAT1260

SPAT

Consultation of another employee

1.8

307.7

7869

31122

T74.1

ICD-10 Finland

Physical abuse

6.8

307.7

1346

1325

F42.0

ICD-10 Finland

Predominantly obsessional thoughts or ruminations

42.0

307.7

795

125

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

107.4

307.7

1461

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

+∞

307.7

396

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

307.7

12784

57965

R42

ICD-10 Finland

Dizziness and giddiness

2.0

307.7

10859

39079

B18.2

ICD-10 Finland

Chronic viral hepatitis C

18.2

307.7

855

311

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

5.3

307.7

1665

2105

N89

ICPC

Migraine

3.0

307.7

1959

4397

SPAT1254

SPAT

Administration of medicine

2.2

307.7

6938

21718

30041

ICD-8 Finland

Neuroses, Depressiva

+∞

307.7

704

F45.0

ICD-10 Finland

Somatization disorder

69.5

307.7

581

WZA90

NOMESCO Finland

Other medical or dental certificate

1.6

307.7

11150

48867

N06AB08

ATC

fluvoxamine; oral

9.7

307.7

1992

1385

SPAT1234

SPAT

Support of social functional capacity

4.3

307.7

2242

3534

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

1046.8

307.7

1712

R4140

NOMESCO Finland

Psychotherapy

57.6

307.7

535

N05AC02

ATC

thioridazine; oral

13.4

307.7

1173

580

Z71.8

ICD-10 Finland

Other specified counselling

2.0

307.7

16959

64978

G47.3

ICD-10 Finland

Sleep apnoea

1.8

307.7

10491

42416

L03

ICPC

Low back symptom/complaint

1.9

307.7

14297

56210

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

307.7

6649

22705

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

1302.3

307.7

410

L28

ICPC

Limited function/disability (L)

2.1

307.7

7351

24340

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

13478.0

307.7

3852

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

307.7

13351

51755

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

18.8

307.7

15541

7500

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

4571.5

307.7

1382

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.2

307.7

6324

19632

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

5.0

307.7

1288

1714

N06BA12

ATC

lisdexamfetamine; oral

18.0

307.7

678

248

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

169.0

307.7

438

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

15.8

307.7

11186

5759

R11

ICD-10 Finland

Nausea and vomiting

2.8

307.7

4706

11542

F43.2

ICD-10 Finland

Adjustment disorders

5.2

307.7

1290

1639

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.7

307.7

9444

38986

Z3231

NOMESCO Finland

Registered nurse

2.2

307.7

14265

49619

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

307.7

6607

25633

P03

ICPC

Feeling depressed

6.8

307.7

9056

10201

F21

ICD-10 Finland

Schizotypal disorder

1130.4

307.7

502

R07.3

ICD-10 Finland

Other chest pain

2.2

307.7

4833

15276

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

42.2

307.7

2038

327

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

250.5

307.7

496

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

59.3

307.7

524

F22.0

ICD-10 Finland

Delusional disorder

139.5

307.7

989

IHZ04, ,

SPAT

10.7

307.7

810

500

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

1441.3

307.7

1117

N06BA04

ATC

methylphenidate; oral

11.9

307.7

2613

1500

KMAK, ,

NOMESCO Finland

1.6

307.7

25629

129583

N06AA12

ATC

doxepin; systemic

6.8

307.7

3477

3503

F32.8

ICD-10 Finland

Other depressive episodes

20.2

307.7

1352

447

ZYY01

NOMESCO Finland

Contact between professionals

88.2

307.7

337

N05BA04

ATC

oxazepam; oral

7.2

307.7

22699

33057

N05CF01

ATC

zopiclone; oral

3.4

307.7

19601

51271

K30

ICD-10 Finland

Functional dyspepsia

1.9

307.7

5437

19290

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

10338.2

307.7

1549

SPAT1284

SPAT

Extensive health certificate

3.4

307.7

1379

2660

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

307.7

11754

46557

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.0

307.7

4873

11406

N05AF01

ATC

flupentixol; systemic

14.7

307.7

1117

506

P72

ICPC

Schizophrenia

157.9

307.7

1256

N05CF02

ATC

zolpidem; oral

3.0

307.7

10865

27566

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

11.6

307.7

904

514

F43.1

ICD-10 Finland

Post-traumatic stress disorder

25.8

307.7

3609

974

D09

ICPC

Nausea

2.9

307.7

2580

5884

R03AC02

ATC

salbutamol; inhalant

1.8

307.7

28142

136055

F41.8

ICD-10 Finland

Other specified anxiety disorders

10.6

307.7

3333

2176

N02BF01

ATC

gabapentin; oral

2.3

307.7

3820

11509

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

270.5

307.7

1690

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

107.2

307.7

7292

514

P02

ICPC

Acute stress reaction

2.8

307.7

3104

7391

J45.9

ICD-10 Finland

Asthma, unspecified

1.9

307.7

8977

33005

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

62.0

307.7

973

104

A02BA02

ATC

ranitidine; systemic

1.9

307.7

8222

31011

N03AX11

ATC

topiramate; oral

5.1

307.7

1612

2092

T82

ICPC

Obesity

2.7

307.7

2036

4939

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

20.7

307.7

746

238

D10

ICPC

Vomiting

2.6

307.7

3398

8701

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

+∞

307.7

490

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

200.8

307.7

2160

N05BA06

ATC

lorazepam; systemic, sublingual

9.3

307.7

3695

2747

N76.0

ICD-10 Finland

Acute vaginitis

2.4

307.7

3342

9547

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

307.7

20149

99160

SPAT1238

SPAT

Brief therapy

4.4

307.7

1047

1559

P58

ICPC

Psychological, Therapeutic counselling/listening

4.5

307.7

1210

1770

N06AX18

ATC

reboxetine; oral

13.0

307.7

742

375

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

3035.3

307.7

469

IBZ06

NOMESCO Finland

Evaluation concerning developmental neuropsychiatry

171.2

307.7

366

E66.01

ICD-10 Finland

Obesity due to excess calories

2.2

307.7

4560

14101

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

89.4

307.7

287

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

4.0

307.7

3191

5434

H03AA01

ATC

levothyroxine sodium; systemic

1.7

307.7

10508

44383

N06AB10

ATC

escitalopram; oral

7.0

307.7

19192

25965

M25.5

ICD-10 Finland

Pain in joint

1.6

307.7

15428

70455

A02BC01

ATC

omeprazole; systemic

1.8

307.7

12797

51770

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

62.5

307.7

467

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

2321.1

307.7

717

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.8

307.7

2022

4801

SPAT1243

SPAT

Psychiatric/psychological examination

7.3

307.7

1964

1814

F41.09

ICD-10 Finland

UNS Panic Syndrome

28.9

307.7

4254

1041

R50.9

ICD-10 Finland

Fever, unspecified

1.8

307.7

6666

25855

A97

ICPC

No disease

1.7

307.7

7988

32869

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

307.7

20083

93996

N05AL01

ATC

sulpiride; systemic

17.9

307.7

984

364

A06AD11

ATC

lactulose; oral

2.6

307.7

6296

17174

N07BB01

ATC

disulfiram; oral

13.9

307.7

3571

1788

AA400

NOMESCO Finland

Electroconvulsive therapy

740.2

307.7

785

F43.8

ICD-10 Finland

Other reactions to severe stress

5.5

307.7

2117

2609

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.9

307.7

5477

19930

F31.5

ICD-10 Finland

Bipolar affective disorder, current episode severe depression with psychotic symptoms

2929.4

307.7

453

D11

ICPC

Diarrhoea

2.4

307.7

6721

19734

F20.9

ICD-10 Finland

Schizophrenia, unspecified

1914.6

307.7

1464

188

Kela drug reimbursment

Psychosis requiring demanding treatment

1322.6

307.7

622

Z08

ICPC

Social welfare problem

9.9

307.7

853

566

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

628.3

307.7

668

F43.23

ICD-10 Finland

Adaptive disorder with other mental disorder

14.6

307.7

451

203

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.5

307.7

2549

6844

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

460.4

307.7

561

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

353.9

307.7

2732

ICB06, ,

NOMESCO Finland

2460.5

307.7

382

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

3.8

307.7

3517

6346

EBA00

NOMESCO Finland

Extraction of tooth

1.8

307.7

17994

78342

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

44.0

307.7

3140

493

XA800

NOMESCO Finland

Neuropsychological investigation

4.0

307.7

2325

3903

P76

ICPC

Depressive disorder

11.5

307.7

6493

4143

ICC01

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric outpatient clinic

2876.5

307.7

445

N02AA05

ATC

oxycodone; systemic

1.9

307.7

6637

24533

ZXY60

NOMESCO Finland

2-person team, nurses

168.8

307.7

514

SPAT1240

SPAT

Therapeutic discussion

5.8

307.7

9102

11978

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

5905.6

307.7

899

N06AX05

ATC

trazodone; oral

16.5

307.7

2296

942

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

442.9

307.7

406

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

10597

47164

1.58

323.01

1.8

1.7

—

(40761511) CBC panel - Blood by Automated count

47613

288956

1.89

318.69

15.9

10.6

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

41329

241766

1.55

318.69

5.8

5.0

38.97

39.03

mmol/mol

0.65

38640

226117

(3024354) Oxygen [Partial pressure] in Venous blood

4390

15249

1.95

318.35

4.2

3.2

4.81

4.63

kpa

5.25

4219

14834

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

2000

4985

2.67

314.66

1.4

1.3

521.89

546.38

mg/l

0.38

1894

4786

(36660697) Celiac disease serology panel - Serum

5484

20648

1.81

310.48

1.2

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

5359

8946

4.23

307.65

3.0

1.2

—

(3019198) Lymphocytes [#/volume] in Blood

28537

131008

1.93

307.65

7.1

5.6

1.98

1.93

e9/l

2.68

25354

117271

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

44276

257018

1.83

307.65

4.8

4.0

5.91

5.81

mmol/l

35.19

41120

237613

(3019309) Folate [Moles/volume] in Red Blood Cells

10767

33658

2.36

307.65

1.8

1.7

1151.37

1162.66

nmol/l

0.58

8409

25535

(3028707) Methadone [Presence] in Urine by Screen method

3870

879

30.87

307.65

3.3

1.3

—

(3035350) Ketones [Presence] in Urine by Test strip

24848

128144

1.50

307.65

4.1

3.3

0.00

estimate

0.23

5149

25323

(3018010) Neutrophils/100 leukocytes in Blood

26487

122510

1.83

307.65

7.0

5.6

56.55

56.70

1.25

24933

115738

(3018095) Leukocytes [#/volume] in Urine

19021

84871

1.72

307.65

4.2

3.4

78.14

84.71

e6/l

0.51

13303

58277

(3000850) Epithelial cells [#/volume] in Urine

11583

48349

1.72

307.65

2.9

2.5

6.52

5.61

e6/l

7.18

10374

43084

(3001122) Ferritin [Mass/volume] in Serum or Plasma

25293

113573

1.88

307.65

3.3

2.7

103.94

117.06

ug/l

7.98

23580

106621

(3017143) Hepatitis C virus Ab [Presence] in Serum

8600

32051

1.89

307.65

1.8

1.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

10340

45683

1.59

307.65

1.3

31.08

35.12

iu/ml

0.49

2850

15364

(3022217) INR in Platelet poor plasma by Coagulation assay

21927

106628

1.59

307.65

12.1

12.8

1.15

1.23

inr

20.84

6732

31915

(3037467) Urinalysis macro (dipstick) panel - Urine

34428

178733

1.75

307.65

5.0

3.9

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

31302

146463

1.99

307.65

11.1

8.3

4.08

4.00

e9/l

7.70

27418

128557

(3019150) Specific gravity of Urine by Refractometry

12372

52555

1.70

307.65

4.3

3.6

1.02

kg/l

0.43

1599

8442

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1246

179

46.36

307.65

1.9

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

10684

35626

2.20

307.65

2.5

1.9

—

(3002032) Base excess in Venous blood by calculation

5246

18715

1.92

307.65

4.7

3.9

1.98

1.83

mmol/l

1.98

4465

16068

(3023103) Potassium [Moles/volume] in Serum or Plasma

47698

272586

2.74

307.65

18.7

12.9

3.93

3.96

mmol/l

91.41

46712

264835

(3009261) Glucose [Presence] in Urine by Test strip

24983

129813

1.49

307.65

4.1

3.3

0.00

estimate

0.10

4897

23573

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

7188

26648

1.88

307.65

2.9

2.7

6.72

8.19

umol/l

7.92

5987

23458

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

9330

39464

1.66

307.65

2.9

2.6

1.17

1.12

e6/l

0.23

5058

22283

(3011288) Drugs identified in Urine by Screen method

4626

4068

8.02

307.65

4.1

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

8965

33549

1.89

307.65

2.0

1.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

22389

88716

2.13

307.65

2.1

1.8

97.67

97.56

pmol/l

0.12

12044

45731

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

28076

123850

2.04

307.65

6.5

6.0

10.01

11.30

umol/l

61.37

26500

117690

(3013826) Glucose [Moles/volume] in Serum or Plasma

29947

142384

1.87

307.65

5.6

4.2

6.54

6.62

mmol/l

7.13

28117

131474

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

11144

45652

1.75

307.65

1.7

1.6

32287578.99

41169693.45

pmol/l

0.79

9431

38349

(3018418) pH of Serum or Plasma

16694

65121

1.98

307.65

4.2

4.1

7.40

3.80

3064

12743

(3027944) Amphetamines [Presence] in Urine

5178

9072

4.01

307.65

2.9

1.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

7525

27735

1.89

307.65

6.4

6.1

1.04

mmol/l

0.29

7031

26032

(3012095) Magnesium [Moles/volume] in Serum or Plasma

9603

35167

1.95

307.65

3.9

3.5

0.82

mmol/l

3.15

8971

33133

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

11941

25703

3.63

307.65

2.2

1.4

1.53

1.28

220.84

10609

23157

(1001926) Buprenorphine [Presence] in Urine by Screen method

4708

5853

5.65

307.65

3.1

1.2

—

(3027008) Opiates [Presence] in Urine

5350

9085

4.16

307.65

3.0

1.2

—

(3048689) Calprotectin [Mass/mass] in Stool

8796

32583

1.91

307.65

2.3

2.5

120.87

133.10

ug/g

2.24

6792

26205

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

36062

181805

1.95

307.65

4.1

2.6

47.44

42.97

u/l

16.79

34061

171542

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

47067

273219

2.32

307.65

17.4

11.4

20.38

22.68

mg/l

43.89

38302

210052

(3002385) Erythrocyte distribution width [Ratio]

41324

239803

1.60

307.65

20.5

13.5

14.76

14.96

0.93

40797

235383

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

8784

36750

1.67

307.65

3.1

2.7

3.99

2.92

e6/l

6.62

4528

19694

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

48487

292921

2.20

307.65

12.5

9.0

27.82

26.52

u/l

22.80

47251

283392

(3022096) Basophils/100 leukocytes in Blood

25336

115193

1.84

307.65

7.1

5.8

0.68

0.69

3.13

23707

108028

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

4543

15435

2.00

307.65

1.7

1.6

—

(3028300) Cannabinoids [Presence] in Urine

5372

9096

4.17

307.65

3.1

1.2

—

(36304419) Bacteria [Presence] in Urine

14849

63528

1.73

307.65

3.4

2.8

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

2070

867

16.13

307.65

5.7

2.7

370.61

360.84

umol/l

1.00

1830

710

(3002030) Lymphocytes/100 leukocytes in Blood

26786

124443

1.83

307.65

7.2

5.8

28.97

28.63

5.78

25232

117645

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

4592

15643

2.00

307.65

3.0

3.6

4.48

4.55

pmol/l

3.92

3975

14217

(3026782) Osmolality of Urine

11092

45383

1.75

307.65

3.1

2.7

519.18

549.26

mosm/kgh2o

28.24

9549

38858

(3006315) Basophils [#/volume] in Blood

27976

126498

1.95

307.65

7.0

5.6

0.04

e9/l

0.04

24297

110688

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

12510

55921

1.60

307.65

1.8

1.5

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

23387

100095

1.95

307.65

2.6

2.2

3898.08

77.39

nmol/l

0.50

21443

91303

(3024561) Albumin [Mass/volume] in Serum or Plasma

23115

98684

1.95

307.65

5.0

4.8

36.29

35.99

g/l

12.67

21449

91989

(3013707) Erythrocyte sedimentation rate by Westergren method

37483

192103

1.97

307.65

4.5

3.8

10.81

11.02

mm/h

2.34

34979

179034

(40758558) Short blood count panel - Blood

14538

61555

1.75

307.65

7.9

6.5

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

13051

54935

1.73

307.65

2.0

1.7

1.05

1.15

mg/l

1.89

9619

41707

(3016879) Cocaine [Presence] in Urine

5171

7993

4.56

307.65

3.1

1.2

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

14392

55009

1.97

307.65

2.4

2.2

2.81

2.90

mg/l

3.95

12351

47503

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

6160

20187

2.12

307.65

2.2

1.8

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

5184

17950

1.98

307.65

7.2

7.3

1.37

1.29

mmol/l

4.58

5034

17569

(40760892) CBC W Ordered Manual Differential panel - Blood

26464

119225

1.91

307.65

7.3

6.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

12599

50958

1.80

307.65

1.5

1.4

2.26

2.33

g/l

3.55

7286

32626

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2275

3050

5.03

307.65

1.4

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

6292

22478

1.93

307.65

1.9

1.6

—

(3012544) pH of Venous blood

5386

19534

1.89

307.65

4.7

3.9

7.36

7.38

1.21

151

(3022948) Iron [Moles/volume] in Serum or Plasma

8799

35563

1.73

307.65

2.6

2.5

13.55

14.21

umol/l

0.59

8188

33416

(3023183) Ammonium ion [Moles/volume] in Plasma

1628

3112

3.48

307.65

2.8

2.7

33.11

34.78

umol/l

1.90

1482

2838

(3024666) Lithium [Moles/volume] in Serum or Plasma

1173

269.14

307.65

12.0

5.9

0.62

0.58

mmol/l

0.46

1085

(3001604) Monocytes [#/volume] in Blood

27901

126265

1.95

307.65

7.0

5.6

0.57

e9/l

1.39

24272

110593

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

14498

58941

1.83

307.65

1.4

1.3

1.46

1.76

u/ml

1.93

3718

16769

(40768797) Stomach Pathology biopsy report

8106

33309

1.69

307.65

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

8772

35533

1.73

307.65

1.4

1.3

478.12

577.11

titre

4.96

1621

7308

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

43701

254838

1.74

307.65

14.8

10.8

89.30

84.10

ml/min/173m2

307.65

36318

209396

(3013115) Eosinophils [#/volume] in Blood

28705

131070

1.95

307.65

7.5

5.7

0.19

e9/l

5.29

25287

116208

(3002582) Erythrocytes [#/volume] in Urine

16161

70882

1.70

307.65

3.6

3.0

53.51

87.13

e6/l

3.36

12436

53482

(3006504) Eosinophils/100 leukocytes in Blood

26055

119219

1.85

307.65

7.1

5.8

2.77

2.90

16.22

24459

112171

(3015377) Calcium [Moles/volume] in Serum or Plasma

19185

74975

2.05

307.65

3.1

3.5

2.35

2.36

mmol/l

3.08

16980

66699

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

9889

31869

2.26

307.65

2.3

1.9

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

18585

73614

2.00

307.65

3.1

2.4

56.05

62.82

u/l

4.79

17179

68204

(3033658) Prothrombin time (PT) actual/Normal

14241

61195

1.71

307.65

4.6

3.7

94.46

91.83

29.87

13804

59748

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

3627

11568

2.12

307.65

2.5

2.2

5356.51

6155.45

u/l

0.69

1196

5021

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

41113

202271

2.56

307.65

4.8

3.7

14.43

14.73

pmol/l

106.07

38144

185257

(3036180) Methadone [Presence] in Urine

1114

184

40.22

307.65

2.6

1.1

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

45438

245087

2.67

307.65

5.9

4.3

1.83

2.12

mu/l

5.57

42757

226737

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

39219

192252

2.35

307.65

8.5

7.1

76.71

76.70

u/l

0.02

37221

181627

(3036481) Cortisol [Moles/volume] in Serum or Plasma

7183

19923

2.56

307.65

2.1

2.3

372.57

375.12

nmol/l

0.44

6534

18548

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

707

377

12.35

307.65

2.6

1.2

156.40

65.66

umol/l

7.16

348

174

(3031040) Bacteria [#/volume] in Urine by Automated count

33548

166592

1.88

307.65

5.4

3.8

1297.59

1212.03

e6/l

0.09

429

2089

(3011397) Hemoglobin [Presence] in Urine by Test strip

12601

57271

1.57

307.65

3.9

3.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

24769

128461

1.49

307.65

5.5

4.4

0.00

estimate

0.14

5009

24229

(3023511) Choriogonadotropin [Units/volume] in Urine

2163

5018

2.88

307.65

1.5

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

13690

55799

1.81

307.65

2.2

1.8

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

5267

18754

1.92

307.65

4.7

3.9

5.90

5.81

kpa

8.85

5085

18298

(3020564) Creatinine [Moles/volume] in Serum or Plasma

48325

290904

2.20

307.65

18.7

13.2

73.12

75.37

umol/l

46.71

48318

290768

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

10187

43372

1.66

307.65

4.1

3.3

267.27

585.79

ng/l

9.17

6751

31842

(3019550) Sodium [Moles/volume] in Serum or Plasma

47638

271550

2.75

307.65

18.7

12.8

139.48

139.73

mmol/l

87.24

46721

264376

(3019069) Monocytes/100 leukocytes in Blood

26213

119902

1.85

307.65

7.4

6.0

8.30

8.49

19.21

24636

113012

(3021387) Prolactin [Units/volume] in Serum or Plasma

3375

9460

2.41

307.65

1.7

1.6

348.84

274.62

mu/l

12.99

3006

8637

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

24595

100431

2.13

307.65

6.5

5.8

1.21

mmol/l

0.17

22721

91807

(3021589) Normoblasts [#/volume] in Blood

23575

114858

1.61

307.65

10.7

8.7

0.00

e9/l

0.74

19222

94963

(3007853) Bacteria identified in Skin by Aerobe culture

7118

27672

1.78

307.65

1.9

1.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

9856

38844

1.80

307.65

2.8

3.1

2.43

2.45

mmol/l

22.50

8490

34120

(3004789) Transferrin [Mass/volume] in Serum or Plasma

8147

32637

1.74

307.65

2.6

2.5

2.42

2.37

g/l

13.26

7480

30451

(3030467) Casts [#/volume] in Urine by Automated count

15039

64585

1.72

307.65

3.5

2.9

0.33

0.37

e6/l

1.46

11435

48253

(3015736) pH of Urine

21405

101861

1.62

307.65

3.8

3.0

5.94

5.87

2.41

1420

9833

(3044889) 12 lead EKG panel

32871

177523

1.56

307.65

3.8

3.3

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

20799

79715

2.16

307.65

3.7

3.0

31.89

32.61

u/l

0.83

19724

76005

(3023368) Bacteria identified in Blood by Culture

13779

58004

1.74

307.65

4.8

4.0

—

(3021960) Folate [Moles/volume] in Serum or Plasma

13236

46042

2.17

307.65

1.6

1.5

20.28

20.64

nmol/l

1.73

11729

39319

(3009508) Creatinine [Moles/volume] in Urine

15860

73236

1.59

307.65

3.5

3.1

7.83

7.82

mmol/l

0.04

13595

62694

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

4958

15898

2.14

307.65

2.1

1.8

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

6250

22337

1.93

307.65

1.9

1.6

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

16863

66538

1.96

307.65

2.5

1.9

212.94

187.23

u/l

1.43

15940

62411

(3026008) Bacteria identified in Urine by Culture

15842

69777

1.69

307.65

3.4

2.7

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

5486

20182

1.86

307.65

2.6

2.3

0.22

g/l

5.31

5049

19055

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

7485

30430

1.70

307.65

2.7

2.5

22.64

23.24

3.03

6464

26276

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

18810

87015

1.64

307.65

4.1

3.0

46.98

54.34

ng/l

0.28

11519

53643

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

26881

111964

2.17

307.65

7.1

6.4

1.21

1.22

mmol/l

1.33

23230

94947

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1018

779

8.65

307.65

1.8

1.1

1.50

0.86

promille

20.01

764

609

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

6438

20878

2.15

307.65

2.9

2.4

41.07

49.24

u/l

0.47

5519

17992

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2651

6993

2.54

307.65

2.0

1.6

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

18783

84206

1.71

307.65

3.7

3.0

—

0.24

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3804

12784

2.01

302.04

3.8

3.3

5.21

5.10

kpa

11.77

3620

12114

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1797

4348

2.75

298.73

1.5

3483.51

2271.46

e6/l

0.24

1428

3542

(3009343) pH of Capillary blood

3754

12622

2.01

297.51

3.8

3.3

7.41

7.42

1.40

500

1650

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1794

4347

2.74

297.42

1.4

35.19

34.43

e6/l

0.02

1344

3365

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

1789

4330

2.75

297.21

1.3

3.73

3.65

mmol/l

1.97

1665

4072

(3000991) Gas panel - Venous blood

4810

17620

1.85

296.40

8.8

8.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

3481

11410

2.06

295.48

1.7

1.6

—

(3042936) Bacteria identified in Isolate by Culture

7784

32767

1.64

294.71

2.2

1.9

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

8111

34537

1.63

293.30

2.4

2.1

29.57

29.74

1.54

7853

33543

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3643

12184

2.02

292.77

3.8

3.3

1.64

1.63

mmol/l

0.07

2726

8889

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

3077

9660

2.14

291.88

5.0

4.5

24.20

24.15

mmol/l

0.40

2988

9516

(3003396) Base excess in Arterial blood by calculation

5990

23577

1.74

290.64

7.7

7.3

1.17

0.95

mmol/l

4.16

4850

18830

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

3602

12036

2.02

290.09

1.6

1.5

—

(3027801) Oxygen [Partial pressure] in Arterial blood

5984

23559

1.74

290.07

7.7

7.4

12.26

13.04

kpa

21.47

5723

22493

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5985

23572

1.74

289.70

7.7

7.4

5.15

5.07

kpa

8.13

5729

22509

(3042517) Benzodiazepines panel - Urine

348

252.13

288.22

3.1

1.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

34342

195356

1.43

280.08

3.7

3.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

2274

6497

2.33

269.21

2.3

391.85

466.22

ug/l

0.58

2095

6065

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

9588

43292

1.54

267.20

1.3

7.74

11.89

u/ml

6.37

3472

17813

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1289

2830

3.01

253.95

1.7

1.6

—

(3000494) Fungus identified in Specimen by Culture

6756

28454

1.63

251.55

1.6

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

1663

4238

2.60

249.92

1.4

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

3837

13860

1.86

244.78

1.4

1.3

24.83

28.05

iu/l

7.04

3186

12179

(3016502) Oxygen saturation in Arterial blood

5291

21047

1.71

244.36

8.2

7.8

95.52

96.05

6.98

5118

20218

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1405

3324

2.80

242.89

1.6

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

709

1051

4.43

242.65

1.8

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2102

6076

2.30

241.94

1.4

292.81

275.22

ug/g

2.24

1144

3557

(3044640) Blood type and Crossmatch panel - Blood

15756

79842

1.41

238.76

2.6

2.2

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

5261

21084

1.69

235.93

1.5

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

4722

18429

1.73

232.79

2.7

10.26

10.62

g/l

7.22

4287

16965

(3009214) Lutropin [Units/volume] in Serum or Plasma

2503

8007

2.09

224.81

1.4

9.81

9.80

u/l

0.01

1979

6719

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

4714

18793

1.69

214.31

1.2

128.83

150.97

iu/ml

2.93

1562

7469

(3020779) Urea [Moles/volume] in Serum or Plasma

4681

18777

1.68

207.64

8.7

7.8

8.23

9.55

mmol/l

33.00

4460

17976

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

4426

17509

1.70

206.58

2.4

2.3

21.92

22.60

au/ml

0.16

270

1631

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3761

14215

1.78

205.86

1.1

1.0

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4850

19727

1.66

203.94

8.6

8.1

123.32

121.69

g/l

6.10

4741

19156

(3019832) Treponema pallidum Ab [Presence] in Serum

7218

32342

1.52

201.82

1.8

1.7

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

2883

10090

1.91

201.10

1.1

9.67

5.79

u/ml

0.20

156

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

3533

13232

1.79

199.11

7.5

7.3

24.98

24.77

mmol/l

2.71

3498

13131

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

4089

15996

1.72

198.32

1.3

49.29

52.63

au/ml

0.30

128

885

(3029937) Albumin [Presence] in Urine by Test strip

13371

67565

1.39

197.52

4.7

3.6

0.00

estimate

6.59

4870

23450

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1463

3936

2.46

196.51

1.4

1.3

24.93

27.16

u/l

1.54

1171

3340

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

226

15.37

196.38

1.2

1.1

—

(3019060) Gas panel - Arterial blood

3466

13073

1.78

190.47

5.3

4.7

—

(3013512) EKG study

13320

67621

1.38

189.75

4.0

3.5

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2159

6960

2.06

189.39

1.2

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

2588

8925

1.93

188.22

1.8

1.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

2161

6988

2.06

188.00

1.2

—

(3019225) pH of Specimen

5161

21752

1.60

187.47

4.3

4.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2134

6897

2.06

185.88

1.2

1.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

12042

60291

1.39

185.79

2.5

2.2

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

544

814

4.38

184.14

1.9

1.3

2176725.36

1904714.27

iu/ml

0.14

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

12100

60705

1.39

184.12

3.1

2.8

1018.58

1218.19

ng/l

4.22

9941

51604

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2473

8488

1.94

182.23

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

13017

66197

1.37

181.93

1.7

1.6

1.52

1.34

mmol/l

64.54

11267

55846

(3022313) Gas panel - Capillary blood

2621

9196

1.90

180.97

4.0

3.4

—

(3007461) Platelets [#/volume] in Blood

49834

312676

1.96

180.04

26.2

16.5

260.59

253.55

e9/l

107.41

48911

304720

(3009542) Hematocrit [Volume Fraction] of Blood

49794

312376

1.95

179.15

26.3

16.6

40.44

40.81

2.66

47277

295091

(3003181) Sodium [Moles/volume] in Urine

1170

2955

2.61

178.49

1.5

1.4

59.41

65.41

mmol/l

4.15

909

2387

(3025941) Bacteria identified in Stool by Culture

3812

15045

1.70

178.22

1.3

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

2756

9964

1.84

173.34

1.3

1.2

0.59

1.00

u/ml

1.56

223

845

(3035941) MCH [Entitic mass]

49839

313011

1.94

172.77

26.1

16.4

30.19

30.20

0.74

49358

309040

(3024731) MCV [Entitic volume]

49842

313054

1.94

172.33

26.1

16.4

90.53

90.51

0.42

49359

309071

(3026361) Erythrocytes [#/volume] in Blood

49843

313092

1.94

171.60

26.2

16.5

4.52

4.55

e12/l

38.54

48815

304364

(3010813) Leukocytes [#/volume] in Blood

49847

313129

1.94

171.51

26.3

16.5

6.84

6.60

e9/l

86.83

48814

304350

(3027945) Reticulocytes/100 erythrocytes in Blood

5412

23530

1.55

171.14

2.7

2.6

1.77

1.74

1.56

4753

21160

(3028026) IgM [Mass/volume] in Serum or Plasma

3634

14320

1.70

170.57

1.9

1.30

1.29

g/l

0.09

3317

13156

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2601

9308

1.86

168.79

3.8

2.8

1.55

1.17

31.88

2586

9257

(3000963) Hemoglobin [Mass/volume] in Blood

49846

313236

1.93

168.68

26.4

16.6

135.56

136.67

g/l

57.64

49362

309308

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

22365

124131

1.30

167.82

2.8

2.5

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2336

8095

1.92

167.07

4.1

3.5

24.78

mmol/l

0.02

2208

7497

(3023410) Appearance of Cerebral spinal fluid

875

1980

2.91

163.43

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

4164

17260

1.62

160.51

1.4

1.3

264.46

229.73

u/ml

0.56

3837

16043

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

4362

18312

1.60

159.59

4.1

3.7

1.23

mmol/l

1.49

3818

16088

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3985

16399

1.63

158.02

3.8

4.0

85.21

89.10

ng/l

1.62

3444

14351

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2520

9159

1.83

155.45

3.8

2.8

0.65

0.21

2509

9121

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

18491

100783

1.30

154.68

4.4

3.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1425

4215

2.23

154.66

1.4

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1425

4217

2.23

154.49

1.4

1.2

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

172

+∞

150.66

6.9

0.0

—

(3052851) Hemolysis interference index of Serum or Plasma

1959

6617

1.96

150.63

3.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

4105

17223

1.60

150.10

1.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

3160

12404

1.70

149.74

4.1

3.3

131.35

129.62

g/l

3.96

3087

12131

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

6142

28163

1.47

149.63

7.5

6.0

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2866

10979

1.74

148.13

9.4

9.8

24.42

24.32

mmol/l

0.95

2744

10696

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

155

19.44

147.87

1.5

1.0

1.99

—

mmol/l

—

(4200892) Spirometry reversibility

4095

17268

1.59

146.43

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

3202

12696

1.68

146.07

8.1

6.6

24.75

24.54

mmol/l

2.55

3086

12023

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

3291

13155

1.67

145.62

9.6

9.2

1.51

1.30

20.45

3275

13073

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

3288

13154

1.67

145.01

9.7

9.3

0.67

0.68

0.06

3274

13089

(3008295) Osmolality of Serum or Plasma

765

1720

2.92

144.48

1.7

1.4

281.22

280.09

mosm/kgh2o

0.58

575

1387

(3014007) Fractional oxyhemoglobin in Arterial blood

3299

13270

1.66

142.42

9.7

9.3

93.60

94.30

7.48

3286

13227

(21494755) Public health laboratory ask at order entry panel

3801

37090

0.64

141.03

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

1944

6746

1.91

138.00

1.3

93.69

129.54

titre

1.54

157

627

(3017181) Myelocytes/100 leukocytes in Blood

4702

20730

1.52

137.70

4.5

4.1

0.95

0.96

0.11

1596

6630

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1668

5543

1.99

134.09

1.3

—

(1616796) Gas panel - Central venous blood

1444

4553

2.09

133.66

4.0

3.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

2419

9111

1.76

132.19

1.3

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1538

4993

2.03

131.79

3.3

3.0

24.82

24.55

mmol/l

1.68

1503

4885

(3017446) Testosterone [Moles/volume] in Serum or Plasma

4369

19151

1.53

131.06

2.6

2.1

12.17

12.72

nmol/l

4.08

3865

17639

(3004716) Salmonella sp identified in Stool by Organism specific culture

3452

14386

1.60

128.97

1.3

1.4

—

(40761535) Cells panel - Urine sediment

4201

18346

1.53

128.04

3.8

3.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1470

4747

2.04

127.74

3.6

3.0

8.68

8.47

kpa

4.37

1434

4635

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

4063

17670

1.54

126.09

2.6

2.1

7.01

7.53

ug/l

0.50

3437

15721

(3018405) Lactate [Moles/volume] in Arterial blood

1915

6813

1.86

125.87

4.7

3.8

1.38

1.34

mmol/l

0.85

1893

6695

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1289

3991

2.13

124.94

1.1

—

(3020891) Body temperature

2141

7914

1.79

124.47

6.1

4.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

4450

19817

1.50

123.56

4.6

4.1

0.12

0.03

1352

5751

(3002179) Metamyelocytes/100 leukocytes in Blood

4287

18947

1.51

123.38

4.2

3.9

0.70

0.68

0.23

1388

5742

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2076

7637

1.80

122.58

1.8

1.7

0.23

g/l

0.12

1959

7264

(3034770) Mitochondria Ab [Titer] in Serum

1879

6703

1.85

122.42

1.2

864.78

1014.91

titre

0.34

212

(3016650) Hepatitis A virus Ab [Presence] in Serum

1290

4038

2.11

121.59

1.2

1.1

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2119

7875

1.78

120.94

1.8

1.7

1.19

1.17

g/l

1.77

2009

7519

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1676

5800

1.91

119.75

1.2

1.3

—

(3010421) pH of Blood

1611

5535

1.92

117.56

4.5

3.5

7.41

7.42

8.24

1442

5119

(3020961) Endomysium IgA Ab [Titer] in Serum

3147

13120

1.60

116.98

1.1

161.68

206.16

titre

0.42

382

(3016018) Differential panel - Cerebral spinal fluid

854

2286

2.45

115.70

1.5

—

(3025159) Blasts/100 leukocytes in Blood

4228

18894

1.50

115.01

4.6

4.1

0.15

0.40

2.29

1129

4912

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2435

9602

1.68

112.58

1.6

1.7

—

(3022145) Colonoscopy Study observation

6022

28902

1.40

112.02

1.3

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

747

1911

2.56

111.04

1.5

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

995

2924

2.24

109.51

2.1

1.8

5477.50

3314.00

titre

0.56

120

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

736

1885

2.56

109.16

2.0

2.2

20.61

18.81

nmol/l

4.20

679

1821

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

376

643

3.82

107.72

1.0

34.65

31.50

ng/l

0.91

286

427

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

375

641

3.83

107.50

1.0

837.67

853.88

ng/l

0.22

281

407

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

374

639

3.83

107.28

1.0

253.90

321.34

ng/l

0.56

288

430

(3023520) Reticulocytes [#/volume] in Blood

3902

17393

1.50

107.10

2.6

2.7

72.68

69.67

e9/l

4.84

2863

13115

(3020630) Protein [Mass/volume] in Serum or Plasma

3919

17510

1.49

106.30

2.4

2.7

66.63

66.75

g/l

0.41

3559

16110

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2271

8934

1.68

105.81

4.5

3.6

51.08

47.94

6.86

2247

8842

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

739

1930

2.51

105.37

1.1

—

(3027315) Oxygen [Partial pressure] in Blood

1412

4825

1.93

104.60

4.6

3.6

8.88

8.76

kpa

1.50

1378

4725

(3012501) Base excess in Blood by calculation

1403

4788

1.93

104.33

4.6

3.5

2.51

2.44

mmol/l

0.38

951

3191

(3013290) Carbon dioxide [Partial pressure] in Blood

1403

4790

1.93

104.20

4.6

3.5

5.09

4.96

kpa

7.43

1369

4690

(3008898) HLA-B27 [Presence]

2423

9748

1.65

103.62

1.1

—

(3043409) Potassium [Moles/volume] in Arterial blood

1643

5920

1.83

103.53

5.1

4.1

3.82

3.88

mmol/l

5.81

1636

5873

(3035637) Corticotropin [Mass/volume] in Plasma

956

2830

2.22

103.41

1.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2414

9747

1.64

101.75

4.1

3.2

25.42

25.27

mmol/l

1.26

2348

9459

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

5445

26097

1.40

101.33

4.0

4.5

232.34

244.04

u/l

7.40

5103

24897

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1541

5495

1.85

100.32

1.3

—

(3024928) Oxygen saturation in Venous blood

1280

4291

1.96

100.18

3.9

3.6

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

2063

8033

1.70

99.72

1.9

1.7

38.74

40.56

nmol/l

2.47

2006

7881

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1460

5157

1.87

97.87

1.3

267.23

256.35

u/ml

0.73

965

3292

(3036489) Thrombin time

2349

9523

1.63

97.35

2.4

2.1

21.30

21.39

0.25

2021

8206

(3017509) Phencyclidine [Presence] in Urine

189

187

6.59

97.27

2.2

1.0

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1518

5443

1.84

97.09

2.1

1.8

193.08

199.96

pmol/l

1.51

1435

5226

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

44285

275258

1.32

96.99

4.9

4.4

2.83

mmol/l

0.83

41235

257820

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

768

2127

2.37

96.74

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

134

10.40

95.55

1.2

1.1

54.99

37.39

mg/l

3.01

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1269

4320

1.93

95.01

1.5

1.4

0.38

0.43

nmol/l

1.02

995

3399

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

706

1913

2.42

93.25

1.1

1.2

35.66

46.37

mg/l

5.65

580

1599

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1046

3350

2.05

92.80

1.3

1.2

—

(3021901) Oxygen saturation in Capillary blood

1112

3653

2.00

92.10

3.0

2.8

—

(1002224) Polysomnography panel

2742

11700

1.55

91.62

1.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

680

1846

2.41

89.47

1.1

237.29

276.62

mg/l

3.57

587

1628

(3029634) Reagin Ab [Titer] in Serum by VDRL

1119

3729

1.97

89.04

2.5

2.1

10.84

5.64

titre

0.83

103

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

578

1454

2.60

88.89

1.6

—

(40767503) Oxygen content in Capillary blood by calculation

1283

4491

1.88

88.38

2.9

2.3

16.95

16.59

2.06

700

2266

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1994

7950

1.66

88.05

1.8

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

43656

271613

1.29

86.36

4.5

4.0

4.70

4.75

mmol/l

19.04

40848

255774

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1835

7201

1.68

86.02

1.3

24.29

36.63

u/ml

1.23

464

(1761868) Lipid panel - Serum or Plasma

14678

110076

0.81

85.52

2.7

2.6

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

392

815

3.14

84.51

1.4

1.5

73.90

72.63

0.96

369

784

(3028271) Lactate [Moles/volume] in Capillary blood

1003

3280

2.01

84.11

2.2

1.7

1.80

1.69

mmol/l

2.22

983

3201

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

2312

9683

1.58

83.59

1.3

221.20

224.07

miu/ml

0.13

962

4862

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

385

797

3.16

83.58

1.4

1.5

555.97

784.87

mu/l

0.79

362

766

(3016244) Insulin [Units/volume] in Serum or Plasma

593

1565

2.48

82.83

3.2

31.09

25.80

mu/l

1.69

554

1483

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

655

1814

2.37

82.56

1.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1445

5362

1.77

82.55

1.2

35.74

44.01

u/ml

1.10

132

546

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

9255

49212

1.27

82.37

1.5

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

539

1362

2.59

82.20

1.4

1.3

5.21

5.12

umol/l

0.18

495

1276

(3016038) Potassium [Moles/volume] in Urine

478

1134

2.76

82.19

1.3

1.2

32.64

35.05

mmol/l

1.20

413

989

(40768804) Tissue Pathology biopsy report

19088

109711

1.21

82.10

2.1

2.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

633

1742

2.38

80.91

1.1

292.94

291.47

mg/l

0.17

562

1573

(3037121) Protein [Mass/volume] in Urine

1957

7937

1.63

80.73

3.3

0.27

0.33

g/l

1.62

875

3556

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

4833

23525

1.37

80.72

3.9

2.9

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2707

11843

1.51

80.44

10.2

9.8

—

(3026389) Candida sp identified in Specimen by Organism specific culture

1048

3541

1.94

80.16

1.4

1.3

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

612

1667

2.40

79.98

1.3

1.2

2.02

2.06

mmol/l

0.31

563

1557

(3041096) Erythrocytes [Presence] in Urine by Automated

13156

73030

1.23

79.52

3.7

2.9

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1384

5129

1.78

79.40

1.4

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

7101

57397

0.77

79.37

3.7

3.9

21.64

21.90

0.61

2703

25797

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

375

791

3.10

79.02

2.7

2.3

52.43

48.59

umol/l

1.41

324

696

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

501

1249

2.62

78.47

1.1

2.32

6.61

nmol/l

1.49

261

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

43314

269897

1.27

77.83

4.4

4.0

1.42

1.48

mmol/l

173.84

40365

253253

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1441

5442

1.74

77.49

1.5

1.4

19.49

21.62

u/ml

0.25

110

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2443

10575

1.53

76.19

1.7

1.6

3.93

3.75

mg/l

0.36

1971

7224

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1929

7912

1.61

75.99

2.2

1.9

2.08

2.39

ug/l

0.49

1703

7058

(3020717) Zinc [Moles/volume] in Serum or Plasma

462

1132

2.67

74.83

1.7

1.4

21.83

28.55

umol/l

4.65

437

1079

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

3638

32103

0.72

74.62

1.6

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1439

5492

1.72

74.56

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

5065

42498

0.75

74.35

2.7

2.8

0.61

0.76

ug/l

25.87

3259

25637

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2191

9331

1.55

73.50

2.2

1.9

—

(3026493) Urate [Moles/volume] in Serum or Plasma

12083

66934

1.23

73.31

2.6

2.5

2307.41

4094.71

umol/l

8.89

10521

59912

(3004588) Protein electrophoresis panel - Serum or Plasma

3106

14228

1.45

73.19

2.2

2.4

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

399

925

2.82

71.61

2.1

1.7

1.99

1.98

umol/l

0.08

373

869

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2390

10445

1.51

71.19

1.5

1.6

9.81

13.57

u/ml

1.11

323

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

972

3335

1.91

71.10

1.3

1.86

1.36

nmol/l

0.20

933

3223

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1824

7501

1.60

71.03

2.9

2.5

180.93

184.09

0.75

1713

7132

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

967

3319

1.91

70.66

1.3

0.20

0.27

nmol/l

0.78

180

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1330

5064

1.73

69.48

1.5

110.92

111.79

u/ml

0.09

266

1168

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1956

8247

1.56

68.51

2.7

2.3

94.50

92.96

2.05

1868

7911

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1995

8455

1.56

68.31

2.1

1.7

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2441

10817

1.49

67.96

2.0

2.1

39.76

39.57

u/l

0.17

2205

9727

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

786

2546

2.02

67.69

1.3

1.2

24.09

25.06

nmol/l

0.07

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

41846

260605

1.23

67.68

4.0

3.6

1.39

1.27

mmol/l

156.59

38678

243230

(3024980) IgG subclass 4 [Mass/volume] in Serum

1117

4081

1.80

67.17

1.6

0.67

0.78

g/l

2.40

867

3071

(3017732) Neutrophils [#/volume] in Blood

3770

18149

1.38

66.77

3.2

2.4

5.06

4.74

e9/l

0.64

3023

15130

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1363

5288

1.69

66.54

1.7

1.6

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

300

620

3.16

65.43

2.8

28.94

27.86

umol/l

0.58

219

490

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1321

5118

1.70

64.81

1.8

1.7

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

573

1668

2.25

64.61

1.2

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1637

6715

1.60

64.36

1.3

8.37

8.97

u/ml

0.12

225

1094

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1657

6818

1.60

64.33

1.2

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

875

3001

1.91

64.10

1.3

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

569

1658

2.25

64.01

1.2

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

31.47

63.66

1.7

1.0

297.76

135.83

nmol/l

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1303

5059

1.69

63.43

2.3

2.1

133.22

131.02

g/l

2.22

964

3654

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1755

7349

1.57

63.27

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

364

862

2.76

62.93

2.2

1.7

28.24

29.48

umol/l

1.19

351

830

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1324

5180

1.68

62.65

6.7

5.8

1145.79

1200.31

iu/ml

0.04

176

788

(3022806) Fractional oxyhemoglobin in Capillary blood

802

2694

1.95

62.44

2.1

1.6

90.34

90.35

0.00

788

2653

(3047181) Lactate [Moles/volume] in Blood

1666

6926

1.58

61.93

6.2

5.5

1.35

1.26

mmol/l

2.48

1478

6116

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

435

1142

2.49

61.56

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

483

1334

2.37

61.37

1.1

1.04

1.08

u/l

0.50

213

623

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1917

8256

1.53

61.00

1.7

1.6

237.05

305.72

titre

0.48

342

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1603

6629

1.59

60.93

1.3

7.35

6.29

u/ml

0.18

143

726

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

422

1098

2.51

60.83

1.1

—

(3012516) Albumin [Mass/volume] in Urine

12259

69049

1.20

60.51

3.3

513.48

411.58

mg/l

1.25

7858

43659

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

331

762

2.84

60.25

1.5

1.4

13.99

15.29

pmol/l

2.90

263

658

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1802

7681

1.54

60.07

3.2

2.6

3.51

3.61

g/l

2.17

1713

7344

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2634

12140

1.43

59.74

2.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

9365

71490

0.82

59.66

4.1

4.5

2.61

2.73

ug/l

0.11

8368

65355

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

802

2737

1.92

59.65

7.1

6.1

11.02

11.32

mg/l

0.97

730

2528

(3006922) Hepatitis E virus Ab [Presence] in Serum

571

1723

2.17

59.11

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2151

9614

1.47

57.24

1.8

1.49

1.50

g/l

0.05

1853

8265

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3626

17772

1.35

56.98

3.0

2.7

145.01

186.46

ng/l

7.77

3238

16115

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1554

6493

1.57

56.52

1.9

16.09

21.38

iu/l

0.17

526

2504

(3020682) Albumin/Creatinine [Ratio] in Urine

12778

72622

1.19

56.32

3.9

3.8

9.56

8.47

mg/mmol

1.41

8039

45848

(3003338) MCHC [Mass/volume]

39195

243677

1.19

56.01

22.6

14.0

332.87

332.93

g/l

0.59

38949

241926

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1853

8087

1.51

55.37

1.4

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

280

617

2.96

55.05

1.4

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1580

6678

1.56

54.66

1.9

1.6

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

241

488

3.22

54.39

1.4

1.2

128.89

123.96

nmol/l

0.16

172

379

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

27.67

54.20

1.7

1.2

343.80

213.67

nmol/l

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1968

8757

1.48

53.51

5.6

4.8

1.88

1.62

13.19

1853

8183

(3001186) Copper [Moles/volume] in Serum or Plasma

251

527

3.11

53.48

1.4

1.3

17.15

16.91

umol/l

0.26

221

465

(3019230) Fractional oxyhemoglobin in Venous blood

980

3701

1.74

52.71

4.2

3.3

64.36

65.87

1.26

974

3686

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

460

1331

2.26

52.71

1.5

5.59

5.83

u/l

0.18

392

1122

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1320

5401

1.60

52.41

1.3

1.2

2.52

5.84

u/ml

1.68

440

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

519

1583

2.14

52.38

1.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

685

2319

1.93

52.21

6.9

5.0

7.15

7.17

mmol/l

0.05

560

1903

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

559

1759

2.08

52.11

2.9

2.5

756.15

666.25

e6/l

1.84

542

1704

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1015

3885

1.71

52.06

3.3

2.8

652.48

7894.47

u/ml

1.30

217

(3007930) Methemoglobin/Hemoglobin.total in Blood

1932

8614

1.48

51.99

5.7

4.9

0.91

0.90

0.30

1821

8053

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1303

5327

1.61

51.91

1.2

10.98

15.12

u/ml

0.23

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

895

3307

1.77

51.89

1.1

1.49

1.48

g/l

0.18

805

3011

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1061

4115

1.69

51.87

1.7

1.6

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

519

1594

2.13

51.49

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1586

6804

1.53

51.31

2.3

2.5

0.61

0.79

g/l

1.52

1381

5926

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1737

7599

1.50

51.29

2.2

2.3

2.83

2.93

g/l

3.90

1561

6892

(3025468) Yersinia sp identified in Specimen by Organism specific culture

817

2949

1.81

51.18

1.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

817

2954

1.81

50.90

1.5

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

817

2959

1.81

50.62

1.5

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

688

2359

1.91

50.53

1.6

1.8

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1789

7899

1.49

50.52

1.1

5.28

5.42

u/ml

0.04

194

1171

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1554

6665

1.53

50.33

1.3

1.5

8.78

13.42

iu/ml

1.31

173

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

972

3713

1.72

50.22

1.8

1.7

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

836

3058

1.79

50.15

1.5

1.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

972

3715

1.72

50.13

1.8

1.7

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

985

3781

1.71

50.01

1.8

1.7

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1436

6062

1.56

49.93

2.2

2.3

0.01

0.02

g/l

0.96

1311

5600

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

388

1069

2.37

49.68

1.3

60.26

68.55

0.68

142

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

819

2988

1.80

49.56

1.5

1.4

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1815

8072

1.48

49.45

2.2

2.3

7.17

7.37

g/l

5.53

1637

7362

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1457

6189

1.55

49.29

2.1

2.2

38.86

37.97

g/l

6.53

1279

5467

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

5638

29860

1.26

49.20

4.3

4.2

30.81

32.41

22.30

4110

21154

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1811

8063

1.48

49.07

2.2

2.3

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

407

1154

2.30

48.90

1.3

1.2

258.18

344.45

u/l

0.88

378

1074

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1807

8054

1.48

48.69

2.2

2.3

3.63

3.70

g/l

0.98

1634

7344

(3012920) Ethanol [Mass/volume] in Serum or Plasma

29.29

48.50

1.7

1.1

—

(40761536) Microorganisms panel - Urine sediment

4331

22247

1.29

48.48

4.7

3.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

5970

31884

1.25

48.33

1.8

1.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

815

2992

1.78

48.32

1.5

1.4

—

(4062490) Immunoglobulin typing, IgG

727

2584

1.84

47.86

1.5

1.4

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

999

3904

1.68

47.51

1.6

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

725

2583

1.84

47.38

1.5

1.4

2.89

3.02

g/l

1.14

529

1777

(3027135) IgG subclass 1 [Mass/volume] in Serum

725

2586

1.84

47.21

1.5

1.4

6.47

6.85

g/l

1.62

532

1778

(3024139) IgG subclass 3 [Mass/volume] in Serum

724

2582

1.84

47.17

1.5

1.4

0.37

0.42

g/l

2.94

535

1778

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

2482

21731

0.73

47.13

1.4

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1698

7529

1.48

46.94

2.1

2.3

9.82

10.21

g/l

3.31

1509

6778

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1327

5588

1.56

46.65

2.2

2.3

0.00

g/l

0.36

1207

5141

(21494815) CD4 cells/100 lymphocytes in Specimen

636

2184

1.91

46.55

2.6

2.1

40.09

38.28

2.26

624

2145

(40757494) Bilirubin.total [Moles/volume] in Blood

362

1006

2.35

45.54

2.2

2.1

16.32

31.12

umol/l

1.33

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1308

5521

1.55

45.51

2.2

2.3

0.00

g/l

-0.00

1205

5129

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

2082

9674

1.42

44.96

1.4

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

1012

4034

1.64

44.64

2.1

2.2

5.87

6.40

umol/l

0.53

748

2955

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1027

4131

1.63

43.72

1.3

1.2

3.66

3.82

u/ml

0.20

467

1878

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

467

1470

2.08

43.59

2.4

2.1

99.22

97.60

0.42

435

1365

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

527

1737

1.98

43.45

1.4

11.26

11.96

umol/l

1.58

490

1680

(3011412) CD3 cells [#/volume] in Blood

678

2435

1.82

43.24

2.7

2.3

1.33

1.18

e9/l

2.31

613

2175

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

329

905

2.37

42.37

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

444

1388

2.09

42.21

1.3

—

(3045716) Anion gap in Serum or Plasma

314

849

2.41

41.97

2.6

9.60

9.80

mmol/l

0.43

303

819

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

378

1111

2.22

41.88

1.6

1.5

—

(3025130) Human papilloma virus identified in Specimen

994

4011

1.62

41.80

1.8

1.7

—

(3051651) Icteric interference index of Serum or Plasma

418

1293

2.11

40.85

4.1

3.9

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

611

2168

1.84

40.53

1.7

1.8

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

775

2957

1.72

40.30

1.7

1.5

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

215

491

2.86

39.91

2.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1047

4328

1.59

39.89

1.3

1.2

3.58

3.72

u/ml

0.09

345

1518

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

965

3918

1.61

39.61

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

714

2681

1.74

39.29

1.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

257

652

2.57

39.20

1.2

1.3

15.90

19.43

0.25

129

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

274

720

2.48

38.94

2.4

2.3

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

305

843

2.36

38.92

1.3

1.2

109.93

111.20

0.31

276

754

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

981

4018

1.60

38.85

1.1

119.94

118.27

0.79

886

3643

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

723

2736

1.73

38.73

2.1

1.9

22.49

26.48

mg/l

1.03

189

709

(3001556) Androgen free Index in Serum or Plasma

141

251

3.66

38.61

1.3

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1546

6998

1.45

38.46

2.1

10.72

10.70

mg/l

0.04

1437

6562

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

492

1654

1.94

38.42

1.2

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

832

3287

1.66

38.05

1.5

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1116

4740

1.54

37.81

2.8

2.0

0.92

0.82

nmol/l

4.21

925

4035

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

909

3679

1.62

37.81

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

468

5603

0.54

37.70

1.5

1.6

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

265

697

2.48

37.61

1.2

—

(3021367) Citalopram [Moles/volume] in Serum or Plasma

65.11

37.54

1.3

1.0

144.52

137.60

nmol/l

—

(3000492) Spirometry study

5201

28071

1.23

37.51

1.5

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1574

7183

1.44

37.50

2.8

2.6

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

555

1961

1.85

37.35

2.7

—

(3019977) pH of Arterial blood

347

1035

2.19

37.18

2.8

2.3

7.41

7.43

1.61

382

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

734

2823

1.70

37.12

1.5

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

221

534

2.70

37.07

3.1

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

221

534

2.70

37.07

3.1

2.4

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

432

1405

2.01

37.05

1.4

1.5

6.37

8.40

ug/l

2.60

396

1267

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

275

742

2.42

37.00

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

559

1987

1.84

36.92

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2485

12266

1.33

36.85

3.0

2.5

0.25

0.27

e6/l

0.31

2402

11893

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

560

1993

1.84

36.85

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

563

2008

1.83

36.79

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

320

927

2.25

36.76

1.3

1.2

0.31

0.30

g/l

0.50

257

737

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

563

2010

1.83

36.68

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

559

1992

1.83

36.64

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

563

2013

1.83

36.51

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

823

3282

1.64

36.32

1.2

1.3

59.57

50.92

u/ml

0.31

224

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

672

2545

1.73

35.94

1.7

1.5

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

672

2545

1.73

35.94

1.7

1.5

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

501

1736

1.89

35.82

2.9

2.5

529.64

529.14

e6/l

0.01

430

1444

(3023420) DNA double strand Ab [Units/volume] in Serum

732

2844

1.68

35.69

1.7

1.6

34.41

36.24

iu/ml

0.10

129

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

563

2031

1.81

35.50

1.2

77.43

67.08

u/ml

—

(3045414) Leukocytes [Presence] in Urine

2316

11385

1.34

35.29

1.9

1.8

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

3837

20160

1.26

35.24

2.9

2.4

72.30

67.52

ml/min/173m2

8.64

1520

7653

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

163

345

3.08

34.50

1.2

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

486

1691

1.88

34.34

2.9

2.5

0.22

0.23

e9/l

0.81

427

1449

(3011985) Renin [Units/volume] in Plasma

822

3328

1.62

34.19

1.6

71.94

60.38

mu/l

0.69

720

3005

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

989

4183

1.55

34.18

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

246

658

2.44

33.77

1.2

1.1

—

(44813793) Dust mix specific IgE antibody measurement

537

1942

1.81

33.62

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

952

4011

1.55

33.48

1.1

869.64

574.46

iu/ml

0.13

221

938

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

505

1796

1.84

33.36

2.4

2.0

—

(3026250) Tacrolimus [Mass/volume] in Blood

360

1143

2.06

33.01

39.0

35.3

7.37

7.35

ug/l

0.04

332

1041

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1464

6752

1.42

32.94

5.5

3.5

1.49

1.44

mg/l

1.30

1356

6263

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

347

1092

2.07

32.57

1.5

1.6

17.66

5.79

nmol/l

0.34

277

911

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1032

4458

1.52

32.41

3.6

3.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

534

1953

1.79

32.24

2.3

2.0

74.26

72.60

1.81

517

1882

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

534

1957

1.78

32.03

1.4

1.3

1.55

1.41

nmol/l

1.84

489

1760

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

282

826

2.23

31.66

2.1

2.5

1.06

1.14

ug/l

0.25

267

780

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

+∞

31.51

3.1

0.0

2.37

—

ug/l

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1026

4471

1.50

30.94

1.1

15.24

11.47

au/ml

0.45

336

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

754

3065

1.61

30.90

1.6

1.4

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

147

313

3.06

30.87

2.1

2.0

1.20

1.19

mmol/l

0.14

140

299

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

473

1690

1.83

30.84

1.2

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

523

1929

1.77

30.73

2.3

2.0

13.17

15.30

5.55

513

1877

(3023419) Bacteria identified in Sputum by Culture

774

3171

1.60

30.72

2.8

2.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

279

826

2.20

30.55

2.1

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

512

1881

1.78

30.49

1.7

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

512

1881

1.78

30.49

1.7

1.8

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

512

1881

1.78

30.49

1.7

1.8

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

479

1733

1.81

30.01

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

611

2374

1.68

29.88

3.6

3.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

748

3076

1.59

29.26

1.3

1.4

350.39

384.07

pmol/l

0.30

650

2710

(3008116) Ketones [Moles/volume] in Urine by Test strip

159

367

2.82

29.13

1.6

1.3

—

(3014271) Vancomycin [Susceptibility]

263

778

2.20

28.89

3.2

2.7

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

166

3.84

28.83

3.8

3.4

2.19

2.30

mg/l

0.20

143

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

1337

6217

1.41

28.76

1.1

2.08

2.26

u/ml

0.23

743

3056

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

786

3285

1.56

28.70

2.5

—

(3034988) Calcium [Moles/volume] in Capillary blood

150

340

2.87

28.39

2.5

2.0

1.19

1.18

mmol/l

0.82

143

326

(3013247) Albumin in CSF/Albumin in Serum or Plasma

196

512

2.50

28.37

1.1

6.10

7.15

mg/g

1.49

182

488

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

367

1241

1.93

28.35

2.3

1.9

141.76

137.75

0.39

345

1176

(3039000) Anion gap in Blood

1071

4804

1.46

28.01

7.7

6.5

11.18

11.11

mmol/l

0.23

975

4304

(3018572) Chloride [Moles/volume] in Blood

1071

4805

1.46

27.98

7.7

6.5

105.00

105.34

mmol/l

1.27

975

4306

(3010015) Selenium [Moles/volume] in Serum or Plasma

161

3.84

27.94

2.3

1.9

1.29

1.33

umol/l

0.47

144

(3017569) Oxygen content in Arterial blood

270

819

2.15

27.93

2.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

619

2463

1.64

27.69

1.8

1.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

739

3071

1.57

27.68

1.2

—

(3011048) Pyruvate [Moles/volume] in Blood

103

4.68

27.62

1.3

1.5

84.79

71.34

umol/l

1.57

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

201

539

2.43

27.56

1.1

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

715

2956

1.58

27.38

1.1

95.33

96.16

0.33

667

2783

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

202

545

2.42

27.35

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

882

3823

1.51

27.34

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1039

4662

1.46

27.14

1.3

1.2

54.78

145.49

titre

2.24

102

(40768443) Skin Pathology biopsy report

2210

11196

1.30

27.12

1.2

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

395

1390

1.85

27.09

2.9

2.7

41.36

39.09

1.42

206

781

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

157

375

2.73

27.07

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

13.42

27.02

1.2

1.0

—

mmol/l

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

1209

5592

1.42

26.82

1.1

5.60

5.70

u/ml

0.07

692

2872

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

936

4124

1.48

26.81

1.1

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

536

2072

1.69

26.77

1.2

166.25

203.43

titre

0.17

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

537

2078

1.69

26.72

1.2

159.58

201.58

titre

0.62

361

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

360

1235

1.90

26.69

1.1

5.43

10.95

u/ml

3.20

211

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

417

1504

1.81

26.47

1.6

1.7

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

202

555

2.37

26.32

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

201

551

2.38

26.32

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

501

1911

1.71

26.28

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

628

2549

1.61

25.99

1.2

65.37

62.42

u/l

0.35

568

2297

(3004616) Nuclear Ab [Presence] in Serum

738

3118

1.55

25.75

1.4

1.3

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

783

3354

1.53

25.68

2.5

2.9

1268.51

543.78

u/ml

0.27

770

3315

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1713

8444

1.33

25.61

1.6

3.29

4.23

iu/ml

0.10

357

1720

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

684

2847

1.57

25.49

2.4

2.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

197

544

2.36

25.41

1.1

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

438

1625

1.76

25.34

2.9

3.4

113.04

131.26

nmol/l

0.58

431

1608

(40768800) Prostate Pathology biopsy report

386

4320

0.58

24.54

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

184

505

2.37

24.09

1.1

—

(3010503) CD19 cells [#/volume] in Blood

410

1516

1.76

24.03

2.9

2.5

0.26

0.35

e9/l

0.41

398

1482

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

162

419

2.52

24.02

1.5

1.6

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

193

3.34

23.99

2.5

3.6

42.78

41.80

umol/l

0.15

161

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

503

1972

1.67

23.90

1.3

1.75

1.94

u/ml

0.15

293

1047

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

297

998

1.94

23.48

1.5

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

297

998

1.94

23.48

1.5

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1136

5325

1.40

23.40

1.1

0.98

1.07

u/ml

0.19

517

2247

(3030313) Adrenal Ab [Titer] in Serum

108

228

3.09

23.14

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

383

1404

1.78

23.13

2.4

2.6

739.51

1112.64

u/ml

3.29

378

1387

(3027923) C peptide [Moles/volume] in Serum or Plasma

338

1195

1.85

22.95

1.6

1.22

1.23

nmol/l

0.10

247

961

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

278

921

1.97

22.90

1.1

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

503

1995

1.65

22.89

4.0

3.8

—

(3029075) Extractable nuclear Ab panel - Serum

235

732

2.09

22.85

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

162

430

2.45

22.80

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1045

4852

1.41

22.75

1.6

—

(3006245) CD3-CD19+ cells/100 cells in Blood

289

973

1.94

22.74

2.6

2.1

10.85

10.11

0.41

273

899

(3010838) Calcium [Moles/time] in 24 hour Urine

998

4598

1.42

22.70

1.9

5.09

5.32

mmol/24h

1.28

886

4130

(3000475) Leukocytes [#/volume] in Synovial fluid

1195

5680

1.38

22.66

1.7

1.6

14244.40

12612.87

e6/l

0.46

840

4189

(3022621) pH of Urine by Test strip

3073

16533

1.22

22.44

3.1

2.7

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

850

3817

1.46

22.21

1.4

1.5

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

106

227

3.04

22.21

1.1

1.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1116

5265

1.39

22.15

1.1

1.92

2.12

u/ml

0.28

627

2509

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

107

231

3.02

22.12

1.1

1.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

584

2425

1.57

22.07

3.6

3.7

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

279

939

1.94

21.99

1.1

296.72

457.31

ng/l

0.33

229

(3028679) Herpes simplex virus Ab [Presence] in Serum

392

1470

1.74

21.94

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

359

1312

1.79

21.93

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

264

875

1.97

21.75

1.1

92.99

90.33

0.66

121

434

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1449

7162

1.32

21.31

4.0

3.1

0.33

0.35

u/ml

1.42

840

4075

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

279

951

1.91

21.22

2.5

2.0

28.63

29.38

0.40

269

900

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

268

904

1.93

21.02

2.3

2.0

156.00

162.50

0.43

257

857

(3042733) HLA Ab [Presence] in Serum

267

900

1.93

20.98

4.4

5.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

139

357

2.54

20.98

1.5

1.3

0.24

nmol/l

0.01

102

245

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

308

1089

1.84

20.96

1.8

1.9

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

350

1289

1.77

20.87

1.4

—

(3028433) Virus identified in Specimen by Culture

241

785

2.00

20.86

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

225

716

2.05

20.75

2.7

2.0

193.79

680.64

e6/l

0.75

145

359

(3014051) Protein [Presence] in Urine by Test strip

1321

6469

1.34

20.71

2.6

2.3

—

(3032057) Clostridioides difficile [Presence] in Stool

149

402

2.41

20.33

2.0

1.8

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

909

4211

1.41

20.11

1.3

1.2

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

262

898

1.90

19.65

1.1

1.2

111.25

107.03

0.90

238

815

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

254

865

1.91

19.42

1.1

93.83

91.01

0.47

117

438

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2736

14763

1.22

19.38

3.2

3.3

54.20

47.47

u/ml

0.25

2630

14296

(3004809) Band form neutrophils/100 leukocytes in Blood

811

3711

1.43

19.24

3.0

3.3

1.41

1.56

0.67

741

3324

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

142

3.44

19.07

1.4

8.29

12.55

pmol/l

0.51

119

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

266

926

1.87

19.06

3.1

2.8

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

305

1112

1.79

18.87

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

312

1146

1.78

18.84

1.2

1.1

3.55

4.03

iu/ml

0.40

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

578

2484

1.52

18.83

4.0

5.0

81.19

123.23

u/ml

0.86

157

815

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1284

6362

1.32

18.61

3.3

3.5

1.55

3.33

ratio

2.49

126

495

(3034860) Kappa light chains.free [Mass/volume] in Serum

1320

6570

1.31

18.53

3.3

3.5

46.30

72.21

mg/l

1.34

1063

5353

(3024869) Neuronal Ab [Presence] in Serum

137

372

2.40

18.49

1.1

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1318

6561

1.31

18.48

3.3

3.5

30.61

43.16

mg/l

4.28

1054

5355

(3045462) Protein/Creatinine [Ratio] in Urine

218

2.87

18.30

5.0

5.8

61.50

51.84

g/mol

0.15

198

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

361

1397

1.69

18.17

1.2

1.3

21.79

22.13

u/l

0.04

309

1212

(3006270) Folate [Moles/volume] in Blood

449

1838

1.59

18.13

1.2

1.1

379.85

382.49

nmol/l

0.09

393

1597

(3035320) C reactive protein [Mass/volume] in Body fluid

440

1795

1.60

18.02

3.0

2.2

—

(3044941) Cell count panel - Synovial fluid

786

3623

1.42

17.94

1.5

1.4

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

219

729

1.96

17.93

1.7

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

430

1748

1.60

17.88

1.1

1.2

1.06

ratio

0.03

131

645

(3033923) Metanephrine [Moles/time] in 24 hour Urine

157

462

2.21

17.71

1.1

0.68

3.81

umol/24h

0.52

235

(3010375) cycloSPORINE [Mass/volume] in Blood

305

1137

1.75

17.56

29.9

28.0

121.44

117.24

ug/l

0.41

253

965

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

109

272

2.61

17.50

1.3

1.4

52.76

55.79

0.23

150

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

407

1642

1.62

17.47

1.6

1.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

307

1150

1.74

17.38

1.3

1.2

151.79

159.13

mmol/24h

0.81

307

1150

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

367

1444

1.66

17.38

1.2

1.3

89.59

83.48

u/l

0.45

321

1269

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

310

1170

1.73

17.11

2.5

2.2

20.72

257.28

ug/l

1.83

297

1119

(3049717) Cytology report of Urine Cyto stain

1535

7881

1.27

17.04

2.3

2.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

220

2.78

17.02

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

621

2770

1.46

16.93

2.9

3.3

6.23

7.52

nmol/l

0.25

594

2687

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

130

360

2.35

16.87

1.1

1.0

86.83

82.34

ug/l

0.48

107

290

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

160

485

2.15

16.83

1.1

2.65

4.81

u/ml

0.52

117

340

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

141

407

2.26

16.67

1.5

1.6

5.91

5.86

nmol/l

0.04

134

391

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

328

1271

1.68

16.48

9.5

5.1

617.63

4614.27

u/ml

0.70

112

211

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

157

3.11

16.43

1.2

16.28

14.08

nmol/l

0.35

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

389

1583

1.60

16.17

1.2

1.1

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

131

373

2.29

16.00

1.7

1.3

799.47

106.00

ng/l

0.44

261

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

251

909

1.80

15.98

1.0

1.1

—

(3042631) Mycobacterium sp identified in Specimen

634

2874

1.44

15.92

2.7

2.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

307

1186

1.69

15.63

1.9

2.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

129

369

2.28

15.61

1.2

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

430

1809

1.55

15.54

1.1

6.53

8.26

iu/ml

0.87

505

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

254

932

1.78

15.50

2.0

2.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1242

6288

1.29

15.44

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

219

769

1.86

15.40

3.5

3.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

306

1188

1.68

15.31

1.9

2.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

127

3.28

15.27

1.9

1.6

48.69

49.22

umol/l

0.04

127

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

249

916

1.77

15.08

2.0

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

249

917

1.77

15.03

2.0

2.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

495

2163

1.49

15.02

1.2

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

364

1487

1.60

14.94

1.6

6.24

6.51

u/l

0.15

280

1221

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

5.93

14.80

5.8

4.0

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

105

281

2.43

14.73

1.3

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

141

430

2.14

14.68

1.3

—

(3038026) Centromere Ab [Units/volume] in Serum

467

2027

1.50

14.65

1.3

1.2

64.81

48.36

u/ml

0.40

100

(3038177) Helicobacter pylori Ab [Presence] in Serum

982

4852

1.32

14.62

1.2

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

172

569

1.97

14.45

1.3

108.19

106.17

0.31

163

542

(40768441) Liver Pathology biopsy report

429

1836

1.52

14.39

1.5

1.4

—

(3021788) Differential panel - Synovial fluid

906

4437

1.33

14.35

1.6

1.5

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

232

849

1.78

14.33

2.0

1.6

46428.57

24856.84

u/ml

0.23

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

281

1088

1.68

14.25

1.2

1.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

263

1001

1.71

14.20

5.6

66.82

3658.17

mg/l

4.68

198

715

(4034850) Laboratory test

1523

7990

1.25

14.14

11.2

8.3

—

(3028717) Thiamine [Mass/volume] in Blood

202

2.68

14.08

1.3

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

922

4545

1.33

13.98

1.1

4.06

4.04

u/ml

0.01

474

2110

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

196

2.69

13.89

1.6

1.56

1.94

mg/l

0.31

120

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

917

4521

1.32

13.89

1.3

3.43

3.73

ug/l

0.46

818

4058

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

161

528

1.99

13.88

1.3

1.2

382.25

292.05

pmol/l

0.95

109

407

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

452

1975

1.49

13.77

1.2

70.04

66.27

u/ml

0.10

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

453

1982

1.49

13.72

1.2

58.53

44.36

u/ml

0.51

157

(40760888) Immunoglobulin light chains.free panel - Serum

991

4951

1.31

13.66

3.3

3.6

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

141

443

2.07

13.65

5.9

5.6

—

(3024932) HLA-DR beta [Type]

239

898

1.73

13.53

1.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

960

4787

1.31

13.43

1.6

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

288

1141

1.65

13.42

1.2

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

131

404

2.11

13.32

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

230

859

1.74

13.31

2.7

2.2

—

(3013336) Amino acids [Identifier] in Serum or Plasma

5.88

13.27

2.4

3.5

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

190

2.67

13.24

2.1

—

(3024471) HLA-A [Type]

242

919

1.72

13.21

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

224

833

1.75

13.16

1.1

1.23

4.99

u/ml

2.14

136

464

(3041806) Other cells [#/volume] in Blood by Manual count

308

1248

1.61

13.14

1.6

1.4

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

501

2258

1.45

13.08

3.1

3.4

56.31

56.55

0.09

435

1933

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

163

549

1.93

13.07

1.1

1.2

90.49

88.45

0.17

171

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

309

1256

1.60

13.02

1.1

98.58

96.42

0.62

245

1003

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

149

487

1.99

13.01

1.0

1.1

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

192

2.64

12.99

1.6

2.78

2.81

mg/l

0.01

127

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

192

2.64

12.99

1.6

1.61

2.01

mg/l

0.42

133

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

192

2.64

12.99

1.6

1.77

2.25

mg/l

0.35

137

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

192

2.64

12.99

1.6

2.74

3.21

mg/l

0.24

135

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

192

2.64

12.99

1.6

1.08

1.61

mg/l

0.62

112

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

192

2.64

12.99

1.6

0.99

1.07

mg/l

0.08

123

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

192

2.64

12.99

1.6

1.95

2.46

mg/l

0.26

121

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

192

2.64

12.99

1.6

3.36

4.46

mg/l

0.76

119

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

192

2.64

12.99

1.6

1.83

1.79

mg/l

0.02

113

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

117

3.17

12.97

1.8

1.5

186.84

163.36

ug/g

0.39

104

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

223

2.51

12.94

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

358

1510

1.55

12.89

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

317

1302

1.59

12.81

1.1

1.2

10.95

13.36

u/ml

0.13

120

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

268

2.36

12.78

1.1

1.0

1.12

2.03

u/ml

0.41

201

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

3.72

12.62

4.5

2.3

—

(3003694) ABO and Rh group [Type] in Blood

13284

81403

1.08

12.57

1.5

—

(3002256) Pathology report gross observation

5848

34489

1.12

12.55

1.3

—

(3002619) Bacteria identified in Specimen by Culture

139

449

2.02

12.55

1.2

—

(3016228) CD19 cells/100 cells in Blood

261

1027

1.66

12.53

2.2

2.0

8.55

8.56

0.01

254

1006

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

430

1902

1.47

12.40

1.2

13.33

9.82

u/ml

0.22

130

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

583

2735

1.39

12.22

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

309

1277

1.58

12.19

1.4

1.3

439.52

486.89

titre

0.06

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

3.74

12.17

4.2

2.3

—

(21494814) CD8 cells/100 lymphocytes in Specimen

255

1008

1.65

12.05

2.2

1.9

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

131

422

2.02

11.94

2.5

2.7

30.45

72.28

mg/l

1.78

(40761539) Cells [Type] in Urine sediment by Light microscopy

161

558

1.88

11.92

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

282

1148

1.60

11.87

3.5

3.3

7.88

8.19

mg/l

0.34

228

918

(3023430) Cat dander IgE Ab [Units/volume] in Serum

854

4275

1.30

11.68

1.1

5.96

4.70

u/ml

0.69

387

1741

(3005011) Chlamydia sp Ab [Titer] in Serum

109

331

2.14

11.59

1.7

1.5

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

4.76

11.59

1.6

1.3

—

(3037756) Immunofixation for Serum or Plasma

862

4331

1.30

11.48

1.8

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

102

303

2.19

11.44

1.4

1.3

—

(37021550) Renin [Units/volume] in Plasma --upright

140

470

1.94

11.41

1.3

107.06

67.61

mu/l

0.34

107

360

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

4.29

11.36

1.0

0.25

0.74

u/ml

0.78

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

238

2.35

11.35

2.0

1.9

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1210

6350

1.25

11.29

1.3

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

402

1792

1.46

11.20

1.0

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

298

1249

1.55

11.12

1.4

1.3

61.07

73.62

titre

0.31

105

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

151

2.72

11.09

4.1

2.0

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

259

1051

1.61

11.08

2.9

2.7

148.68

141.11

au/ml

0.08

135

(3020123) Porphyrins [Interpretation] in Serum or Plasma

133

2.84

11.05

1.2

1.0

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

266

2.25

11.02

1.0

2.43

3.61

u/ml

0.28

205

(3044927) Protein electrophoresis panel - Urine

439

1999

1.43

10.95

1.3

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

842

4248

1.29

10.90

1.1

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

223

875

1.66

10.90

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

156

553

1.84

10.83

1.1

71.51

78.09

0.78

165

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

188

2.49

10.76

1.2

1.1

—

(3000330) Specific gravity of Urine by Test strip

2139

11914

1.17

10.73

3.6

3.1

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

115

369

2.03

10.66

1.6

1.8

76.66

52.25

pmol/l

0.28

312

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

151

2.67

10.62

1.5

34.46

35.07

0.04

107

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

159

2.62

10.56

1.0

0.21

2.42

u/ml

1.47

126

(3008037) Lactate [Moles/volume] in Venous blood

919

4710

1.27

10.53

3.5

2.8

1.51

1.53

mmol/l

0.33

902

4611

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

306

1307

1.53

10.52

1.1

1678.24

1462.06

miu/ml

2.46

306

1307

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

339

1481

1.49

10.48

1.5

25.10

22.71

u/ml

0.34

264

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

578

2781

1.36

10.45

2.1

2.2

32.43

32.58

0.35

571

2763

(3034426) Prothrombin time (PT)

232

932

1.62

10.38

1.3

1.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

107

339

2.05

10.27

2.1

2.4

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

290

1233

1.53

10.20

1.2

1.1

90.70

80.73

u/l

0.81

269

1126

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

132

2.76

10.20

1.5

1.6

11.03

13.22

0.30

102

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

290

1235

1.53

10.13

1.2

1.1

27.70

21.71

u/l

0.57

271

1127

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

637

3126

1.33

10.12

1.2

1.1

2.04

2.16

iu/ml

—

(3051339) Copper [Moles/volume] in Blood

105

2.97

9.95

1.3

1.2

16.40

16.65

umol/l

0.13

(3027231) Wheat IgE Ab [Units/volume] in Serum

154

559

1.79

9.95

1.1

1.65

4.25

u/ml

0.69

122

480

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

287

2.13

9.93

1.0

0.11

0.21

u/ml

0.50

170

(3045424) Erythrocytes [Presence] in Urine

856

4384

1.27

9.90

1.6

1.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

218

873

1.63

9.90

1.3

1.2

0.51

0.54

g/l

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

146

2.63

9.84

1.2

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

222

896

1.61

9.78

1.1

1.0

9.98

12.65

u/ml

0.93

127

535

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

113

373

1.97

9.74

1.0

0.27

0.33

u/ml

0.10

235

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

143

513

1.82

9.62

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

253

2.19

9.58

1.3

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

228

2.26

9.57

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

119

2.79

9.48

1.1

1.0

—

(4146454) Self-monitoring of blood glucose

492

2346

1.37

9.47

2.7

2.8

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

105

343

1.99

9.33

2.4

2.0

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

210

2.29

9.32

1.0

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

166

2.47

9.30

1.2

1.1

1.37

3.20

u/ml

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

199

794

1.63

9.21

2.2

1.8

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

320

1425

1.46

9.08

1.5

1.4

11.89

12.73

u/l

1.44

310

1379

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

242

2.18

9.07

1.0

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

300

1320

1.48

9.04

1.2

1.3

—

(3033942) Copper [Moles/time] in 24 hour Urine

101

2.90

8.97

1.2

1.3

0.98

0.96

umol/24h

0.01

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

104

344

1.97

8.95

1.2

1.3

34.34

41.10

mg/l

0.83

294

(3006576) Bicarbonate [Moles/volume] in Blood

188

746

1.64

8.91

5.9

6.7

25.08

25.02

mmol/l

0.08

175

669

(3020491) Glucose [Moles/volume] in Blood

407

1903

1.39

8.86

1.7

6.65

6.51

mmol/l

0.43

308

1393

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

151

2.50

8.80

1.0

1.1

7.53

9.65

u/l

0.47

151

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1221

6592

1.21

8.78

1.5

1.4

130.44

125.21

pmol/l

0.13

1191

6433

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

101

333

1.97

8.78

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

142

524

1.76

8.76

1.6

0.37

0.40

ug/l

0.32

354

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

552

2713

1.33

8.75

1.1

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

110

2.78

8.72

1.4

1.3

1.59

1.87

0.11

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4111

24254

1.11

8.69

3.5

4.2

19.84

25.26

ug/l

0.62

3228

19177

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

104

348

1.95

8.68

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

228

957

1.55

8.59

1.1

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

2.94

8.58

1.1

459.66

329.37

u/l

0.34

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

306

2.00

8.48

1.7

1.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

275

1206

1.49

8.46

1.1

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

101

2.83

8.46

1.5

1.4

0.00

0.16

u/l

1.02

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

104

352

1.92

8.42

1.0

1.1

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

113

2.71

8.33

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

111

386

1.87

8.30

1.2

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

298

1334

1.46

8.28

1.6

1.5

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

243

2.12

8.28

2.9

2.3

0.86

1.47

mmol/l

1.97

175

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

293

1308

1.46

8.26

1.8

1.7

2.31

2.57

u/field

0.24

207

935

(3013762) Body weight Measured

2.90

8.21

1.1

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

228

968

1.53

8.19

3.8

3.9

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

268

1178

1.48

8.17

1.7

1.5

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

162

634

1.66

8.14

1.1

—

(3000012) Reticulocyte production index

584

2925

1.30

8.13

2.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

127

2.56

8.00

1.1

1.0

—

(3018133) Calcium [Moles/volume] in Urine

111

391

1.85

8.00

2.0

2.1

2.68

2.80

mmol/l

0.22

103

350

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1024

5489

1.22

7.97

2.4

127.47

99.00

ug/min

0.87

617

3360

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

139

2.48

7.96

1.1

1.2

22.70

21.32

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

269

1192

1.47

7.90

1.7

1.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1106

8601

0.83

7.82

1.8

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

162

1673

0.63

7.79

1.2

1.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

237

2.09

7.72

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

146

2.41

7.64

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

832

4386

1.24

7.62

1.1

2.80

2.88

u/ml

0.08

334

2346

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

711

3688

1.26

7.53

1.1

1.0

0.39

0.38

u/ml

0.03

223

885

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

5604

33790

1.09

7.49

1.5

1.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

136

2.44

7.43

1.1

1.0

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

144

2.40

7.43

1.0

0.31

0.56

u/ml

0.41

136

(40768446) Kidney Pathology biopsy report

242

1065

1.48

7.39

1.9

1.7

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

291

1.95

7.35

1.1

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

3.51

7.29

1.1

1.2

267.83

425.80

pmol/l

0.63

(3036603) Volume of Urine

355

1682

1.38

7.24

1.5

1.6

2056.39

1954.31

1.14

348

1637

(3013945) Hepatitis B virus e Ab [Presence] in Serum

142

2.38

7.22

1.5

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

235

2.05

7.21

1.2

1.1

1.58

3.28

umol/24h

0.57

235

(3020876) Protein [Mass/time] in 24 hour Urine

491

2450

1.31

7.10

2.8

2.6

1.31

1.32

g/24h

0.01

250

1284

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

686

3570

1.25

7.09

1.3

30.66

32.56

u/l

0.15

597

3116

(40757373) Influenza virus identified in Isolate

111

407

1.78

7.09

1.8

1.6

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

108

2.59

7.08

1.0

0.21

0.11

u/ml

0.40

(3016750) Collection duration of Urine

295

1361

1.41

7.05

2.3

2.2

520.69

495.83

min

4.66

227

1043

(3051593) INR in Capillary blood by Coagulation assay

207

892

1.51

7.02

5.6

11.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

3.72

7.00

2.0

2.9

2.02

1.95

mu/l

0.04

(40763480) Human metapneumovirus Ag [Presence] in Specimen

105

2.60

6.98

1.5

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

107

390

1.79

6.98

1.5

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

914

7151

0.83

6.95

1.4

1.5

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

125

478

1.70

6.92

1.2

—

(4035726) Immunohistochemistry procedure

3793

22552

1.10

6.91

1.5

1.4

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

294

1.90

6.85

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1628

9218

1.15

6.74

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1627

9212

1.15

6.74

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

536

2727

1.28

6.72

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1624

9198

1.15

6.70

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

259

1179

1.43

6.70

1.2

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1826

10430

1.14

6.68

1.5

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1619

9173

1.15

6.65

1.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

194

835

1.51

6.65

1.8

1.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

136

2.34

6.61

1.2

1.3

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

161

2.22

6.58

1.0

19.26

16.54

u/ml

0.11

133

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

178

2.16

6.57

1.0

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

150

2.26

6.45

1.5

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

458

2297

1.30

6.43

1.4

1.3

—

(3038515) Glucose [Moles/volume] in Venous blood

832

4470

1.21

6.43

3.7

2.9

7.21

7.43

mmol/l

1.19

818

4390

(3010144) Erythrocytes [#/volume] in Synovial fluid

439

2191

1.31

6.39

1.4

63792.26

110674.92

e6/l

1.28

318

1509

(3003129) Base excess in Capillary blood by calculation

130

515

1.64

6.35

1.6

1.7

1.02

0.44

mmol/l

0.88

121

487

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1720

9837

1.14

6.20

1.4

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

166

702

1.54

6.20

1.6

9.35

8.89

ug/l

0.60

166

702

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

153

2.21

6.18

1.2

6.53

3.95

u/ml

0.21

122

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

235

1068

1.43

6.17

3.0

3.4

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

532

2739

1.27

6.10

1.4

8.66

7.93

mmol/l

3.47

518

2644

(3022229) Phosphate [Moles/volume] in Urine

125

2.34

6.09

1.8

2.2

18.43

19.83

mmol/l

0.26

101

(3004451) EKG impression Narrative

228

1034

1.44

6.07

1.4

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

413

2061

1.31

6.05

1.9

1.7

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

208

928

1.46

6.03

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

1284

7218

1.16

5.92

1.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.90

5.90

1.0

307.71

181.54

pmol/l

0.64

(3024263) Appearance of Synovial fluid

257

1199

1.40

5.86

1.5

1.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

237

1.92

5.81

1.0

1.1

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

3.19

5.68

1.0

2.23

0.37

u/ml

0.41

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

231

1066

1.41

5.62

1.9

2.0

8.64

9.55

mg/l

1.52

182

853

(3049233) Organic acids panel - Urine

7.69

5.61

1.1

1.4

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

191

2.01

5.56

1.1

1.0

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

360

1788

1.31

5.51

1.4

29.31

32.88

nmol/l

1.37

324

1662

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.42

5.50

1.1

1.76

2.85

1.18

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

183

2.03

5.50

1.0

0.18

2.22

u/ml

1.91

118

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

240

2142

0.73

5.48

1.2

1.3

1.54

g/l

0.05

240

2142

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

190

850

1.46

5.48

1.6

1.7

118.55

134.74

au/ml

0.19

103

(40762365) Oxygen content in Arterial blood by calculation

342

1.73

5.46

3.0

2.8

14.97

14.84

ml/dl

0.15

323

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

367

1.70

5.43

1.1

2.92

8.76

pmol/l

0.69

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

3.64

5.42

1.1

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1344

7637

1.15

5.39

1.4

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1489

8522

1.14

5.37

3.0

3.6

4566.53

1580.88

u/ml

0.33

1255

7344

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

2.57

5.27

1.0

1.1

0.19

0.21

g/l

1.13

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

351

1.71

5.25

1.4

1.5

100004.95

276981.35

nmol/l

0.69

304

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

232

1087

1.39

5.21

1.5

—

(3042951) Complement C1q Ab [Units/volume] in Serum

122

2.24

5.20

1.1

1.3

21.50

20.32

u/ml

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

387

1.67

5.18

4.6

4.7

49.10

43.14

ug/min

0.34

296

(3036071) Salmonella sp Ab [Titer] in Serum

198

904

1.43

5.16

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

188

1.97

5.14

1.0

0.49

0.94

u/ml

0.61

103

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

231

1087

1.38

5.07

1.5

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

194

1.95

5.03

1.4

1.3

1.30

1.65

ml/s/173m2

0.33

123

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

288

1.76

5.01

1.0

1.1

0.13

0.72

u/ml

0.92

157

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.57

4.95

1.1

1.0

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

129

2.17

4.95

1.1

1.21

1.15

u/field

0.21

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

294

1.75

4.94

1.0

0.78

3.61

u/ml

0.72

161

(40768793) Breast Pathology biopsy report

1095

6175

1.16

4.92

1.3

—

(3005033) Fetal Nuchal fold Thickness US

1307

7464

1.14

4.91

1.4

1.5

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

3.25

4.91

1.0

0.06

0.12

u/ml

0.25

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.58

4.85

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.38

4.82

1.4

1.5

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

338

1698

1.30

4.82

2.0

1.6

—

(3017704) Immunofixation for Urine

240

1147

1.36

4.82

1.8

1.7

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

3.10

4.81

1.0

1.1

—

(3012898) Urea [Moles/volume] in Urine

235

1.83

4.78

1.5

158.80

178.21

mmol/l

0.62

211

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.66

4.78

1.2

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.55

4.74

1.0

—

(37019676) Renin [Units/volume] in Plasma --supine

3.25

4.67

1.1

1.0

78.54

68.04

mu/l

0.06

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

137

595

1.50

4.65

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

137

595

1.50

4.65

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

137

595

1.50

4.65

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

137

595

1.50

4.65

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

217

1030

1.37

4.57

1.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

147

652

1.47

4.52

1.4

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

184

1.91

4.49

1.2

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1302

7485

1.13

4.46

1.4

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

403

2095

1.25

4.40

3.0

2.9

64.59

52.37

mg/l

0.37

282

1484

(3013931) Oligosaccharides [Presence] in Urine

+∞

4.38

1.2

0.0

—

(3032641) Amino acids panel - Urine

5.58

4.31

1.2

1.3

—

(40759632) Porphyrins [Mass/mass] in Stool

4.55

4.26

1.2

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

409

1.58

4.24

2.3

2.4

6.83

7.55

mmol/l

1.09

238

(3033705) Calcium.ionized [Moles/volume] in Venous blood

480

2555

1.22

4.24

2.8

2.2

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

221

1.80

4.23

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

391

2037

1.25

4.22

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

142

636

1.45

4.19

2.3

2.7

98.35

106.53

ng/l

0.27

320

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

175

1.90

4.18

2.9

2.7

108.30

430.61

pmol/l

0.37

(3024316) Viscosity of Plasma

104

2.19

4.18

1.7

1.57

1.48

mpas

0.48

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1032

5874

1.15

4.15

1.8

1.7

—

(3043410) Blood group antigens tested for on Red Blood Cells

146

661

1.44

4.08

1.9

1.6

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

388

1.58

4.06

1.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

136

2.01

4.06

1.0

1.1

—

(3004775) Volume in Urine collected for unspecified duration

352

1821

1.26

4.05

2.4

2.3

680.73

672.34

0.14

269

1277

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

435

2310

1.23

3.96

1.6

30.96

33.47

0.69

274

1444

(36303858) Crystals [Presence] in Urine

3.25

3.96

1.2

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.27

3.90

1.0

1.1

2.13

0.95

u/field

0.46

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1274

9278

0.89

3.88

1.5

1.6

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

125

2.03

3.88

1.1

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

3.07

3.86

1.1

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

121

2.04

3.85

1.0

1.1

40.79

116.24

u/l

0.79

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

116

509

1.48

3.83

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

144

1.94

3.81

1.3

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

268

1.68

3.81

1.0

1.1

0.13

0.58

u/ml

1.41

150

(3022475) Manganese [Moles/volume] in Blood

173

1.84

3.73

1.2

1.3

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

3.25

3.72

3.2

4.2

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

197

1.78

3.71

1.1

34.73

22.53

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

197

1.78

3.71

1.1

47.82

31.23

u/ml

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

834

4719

1.15

3.70

3.2

3.5

382.23

908.38

u/ml

1.55

747

4304

(21494890) Protein electrophoresis panel - 24 hour Urine

420

2244

1.22

3.65

2.1

2.2

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

287

1.63

3.62

1.1

1.6

—

53.32

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

2.12

3.60

1.0

0.23

0.04

u/ml

0.83

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

116

2.02

3.56

7.2

9.5

578.29

246.38

e6/l

0.38

(3002523) Influenza virus A Ag [Presence] in Specimen

901

5141

1.14

3.56

1.1

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

5.85

3.46

1.1

1.0

18.56

13.90

umol/l

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.14

3.46

1.8

1.3

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.53

3.45

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

899

5146

1.14

3.40

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

194

953

1.33

3.39

1.0

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

123

1.96

3.38

1.1

1.3

—

438.57

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.72

3.38

1.0

1.3

86.67

56.83

e6/l

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

170

1.80

3.35

1.1

1.2

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

2.43

3.33

4.2

5.1

8.10

6.46

mg/l

0.20

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

471

2571

1.19

3.31

1.9

2.0

23.74

24.61

ug/l

0.10

463

2519

(3018738) Hemoglobin F/Hemoglobin.total in Blood

166

1.80

3.31

2.8

3.1

23.80

10.28

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

246

1255

1.28

3.27

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

107

479

1.45

3.26

2.0

2.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

273

1413

1.26

3.23

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

226

1.67

3.22

1.0

1.1

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

352

1876

1.22

3.19

2.1

1.9

2.24

2.30

u/field

0.07

176

816

(3044009) aPTT.lupus sensitive (LA screen)

247

1.63

3.18

1.2

—

(3006462) Nitrate [Presence] in Urine

244

1249

1.27

3.17

3.4

2.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1983

11904

1.09

3.10

1.5

1.4

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

326

1.54

3.08

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

174

855

1.32

3.08

1.1

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

114

1.94

3.07

1.2

1.3

1581.93

1116.33

u/l

0.11

105

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

416

1.47

3.06

3.8

6.7

68.44

71.95

0.67

330

(3027570) Oxalate [Moles/time] in 24 hour Urine

166

1.76

3.04

1.8

1.3

343.60

322.27

umol/24h

0.29

166

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

138

656

1.37

3.03

1.9

43.24

31.12

u/l

0.42

120

596

(3013166) Neutrophils/100 leukocytes in Synovial fluid

143

686

1.36

2.98

1.4

55.85

52.21

0.51

120

594

(3041672) Baker's yeast Ab [Presence] in Serum

154

1.77

2.91

1.0

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

264

1.58

2.89

3.4

2.2

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

120

565

1.38

2.82

1.2

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

424

1.44

2.81

1.4

27.04

27.56

g/l

0.10

339

(3033799) Differential panel - Peritoneal fluid

128

610

1.37

2.80

2.0

1.7

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

120

566

1.38

2.80

1.2

1.1

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

137

1.80

2.79

1.1

3.17

2.65

u/l

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.06

2.78

1.0

1.1

198.30

301.81

nmol/l

2.17

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.17

2.77

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

120

567

1.38

2.77

1.2

1.1

—

(3042628) Porphyrins [Moles/volume] in Urine

5.69

2.75

1.1

1.0

—

(3003843) Paprika IgE Ab [Units/volume] in Serum

2.24

2.73

1.0

0.04

0.08

u/ml

0.37

(3035933) Granulocytes/100 leukocytes in Blood

161

798

1.31

2.73

2.3

1.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

362

1969

1.20

2.73

1.1

3.06

2.90

u/ml

0.03

145

582

(3007916) DNA double strand Ab [Titer] in Serum

347

1.48

2.71

1.3

132.80

156.41

titre

—

(3012565) Volume of 24 hour Urine

244

1276

1.24

2.71

2.2

1945.89

2003.27

0.30

225

1155

(3045177) Copper [Moles/volume] in Urine

2.64

2.70

1.0

1.1

0.21

0.56

umol/l

—

(3036670) Protein [Mass/volume] in Synovial fluid

139

681

1.33

2.58

1.3

1.2

38.74

40.43

g/l

0.80

372

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

551

3118

1.15

2.57

1.6

53.97

55.38

0.33

344

2014

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

210

1087

1.26

2.57

2.2

2.1

62.77

83.17

ug/min

0.29

239

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.94

2.56

10.8

8.9

—

(3050794) Legionella sp Ab [Presence] in Serum

216

1.60

2.55

1.2

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

268

1.53

2.53

2.4

2.2

0.56

0.66

u/field

0.44

268

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

760

4400

1.13

2.52

3.7

3.5

33.02

39.35

u/ml

0.79

725

4260

(3023487) Leukocytes [#/volume] in Peritoneal fluid

148

735

1.31

2.51

2.4

1.8

601.37

3754.76

e6/l

1.59

102

500

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

353

1936

1.19

2.47

1.9

1.8

3.60

3.56

mg/l

0.05

328

1854

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

310

1681

1.20

2.46

6.6

6.7

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

346

1.45

2.40

2.0

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

131

645

1.32

2.38

2.4

1.8

4089.36

12285.86

e6/l

1.54

342

(3019174) dRVVT (LA screen)

236

1.54

2.37

1.2

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.64

2.36

1.6

1.3

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

1.99

2.30

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

132

1.72

2.28

3.2

4.8

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

107

515

1.35

2.27

1.3

1.2

44.52

44.81

mg/l

0.00

358

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

383

1.41

2.27

1.3

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.69

2.26

2.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.69

2.26

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.69

2.26

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.69

2.26

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.69

2.26

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.69

2.26

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.13

2.24

9.2

8.5

—

(3000219) Insulin receptor Ab [Presence] in Serum

6.50

2.23

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

298

1.46

2.23

3.1

2.8

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

168

1.63

2.22

1.0

1.1

1.92

0.94

u/ml

0.43

121

(36304079) Mucus [Presence] in Urine sediment

4.88

2.19

1.0

1.1

—

(3036005) Urine sediment comments by Light microscopy Narrative

2.96

2.16

1.0

1.1

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

126

627

1.31

2.16

1.2

—

(3013293) Extractable nuclear Ab [Presence] in Serum

401

1.38

2.08

1.8

1.6

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

187

1.57

2.06

1.0

1.1

10.38

7.16

u/ml

0.38

133

(3023199) Leukocytes [#/volume] in Pleural fluid

414

2339

1.15

2.06

1.5

4033.19

2084.59

e6/l

1.34

316

1668

(3012989) Citrate [Moles/time] in 24 hour Urine

2.09

2.05

1.7

1.3

1.84

2.30

mmol/24h

0.94

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

2.09

2.05

1.7

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

178

1.57

2.01

1.2

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

322

1.41

1.99

2.2

2.6

—

(3029612) Listeria sp Ab [Titer] in Serum

2.17

1.99

1.6

1.3

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

216

1.51

1.95

1.0

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

424

1.35

1.91

1.3

1.4

232.55

167.60

titre

0.13

(3011335) Digoxin [Mass/volume] in Serum or Plasma

176

0.48

1.91

2.5

2.2

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

2.44

1.91

1.0

0.13

0.30

u/ml

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

201

0.52

1.88

1.2

1.3

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

171

1.56

1.88

1.2

1.1

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

332

1.39

1.86

2.6

65.61

76.09

pmol/l

0.22

289

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

179

953

1.22

1.81

1.2

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

3.25

1.80

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

971

5820

1.09

1.74

4.7

3.6

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

3.55

1.73

1.0

55.00

21.82

umol/l

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.75

1.71

1.3

1.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

2.39

1.69

1.1

1.0

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

224

1230

1.19

1.67

1.5

5.27

4.02

0.38

292

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

2.00

1.67

10.0

8.5

47.73

41.22

0.39

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

333

1887

1.15

1.66

2.1

1.9

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

323

1.37

1.66

1.8

1.7

1.57

1.69

mg/l

0.30

269

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

274

1.40

1.64

1.3

1.2

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

3.25

1.60

1.0

1.1

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

3.25

1.60

1.0

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

188

1023

1.20

1.57

1.7

1.6

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

492

1.28

1.54

1.8

1.2

12.42

14.28

g/l

0.93

391

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.78

1.52

3.1

3.4

—

(3027035) Albumin [Mass/time] in 24 hour Urine

224

1.42

1.51

1.4

1.2

178.51

330.56

mg/24h

—

(3000285) Sodium [Moles/volume] in Blood

268

1.38

1.50

1.3

1.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.32

1.47

1.0

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.68

1.45

1.1

1.4

1.44

1.07

u/field

—

(3036782) Glucose [Moles/volume] in Pleural fluid

333

1909

1.14

1.45

1.3

6.28

6.31

mmol/l

0.07

308

1781

(40762887) Creatinine [Moles/volume] in Blood

1.98

1.44

1.3

1.2

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

126

667

1.23

1.42

1.3

1.4

60.37

62.99

0.38

103

552

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

310

1773

1.14

1.41

1.3

628.16

446.11

u/l

0.76

290

1690

(3013466) aPTT in Blood by Coagulation assay

179

1.45

1.40

1.1

34.93

36.84

1.32

155

(3009677) Dengue virus Ab [Presence] in Serum

117

1.56

1.34

1.1

1.2

—

(44786800) Granulocytes/100 leukocytes in Body fluid

219

1.40

1.34

1.2

1.3

23.79

23.85

0.00

169

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

154

1.48

1.34

1.3

1.1

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

149

1.48

1.32

1.2

114.74

111.38

ug/l

0.04

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

359

2612

0.89

1.32

1.4

1.5

—

(3025566) Toxoplasma gondii IgG Ab [Units/volume] in Cerebral spinal fluid

2.96

1.29

1.0

1.1

—

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

2.96

1.29

1.0

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

227

1.38

1.27

1.3

1.2

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

1.63

1.26

1.2

1.1

0.08

0.06

g/l

0.61

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

151

1.46

1.25

1.4

22.01

21.47

mmol/l

0.26

105

(40761995) Spermatozoa Progressive [#/volume] in Semen

119

932

0.83

1.21

3.3

3.2

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

1.95

1.21

1.0

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.70

1.20

1.1

1.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

119

931

0.83

1.20

6.7

6.3

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

126

1.50

1.20

1.0

1.1

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

2.71

1.18

1.2

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

236

1.35

1.18

1.0

1.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

132

1.48

1.17

3.7

3.3

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

170

1.42

1.17

4.6

5.5

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

209

1.37

1.15

1.1

24.50

21.42

u/l

0.29

141

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

2.40

1.13

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

624

3755

1.08

1.13

1.8

1.6

—

(40768795) Lymph node Pathology biopsy report

378

2711

0.91

1.11

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

438

2600

1.10

1.5

34.39

33.63

g/l

0.61

396

2352

(3028468) Fragments [Presence] in Blood by Light microscopy

2.50

1.09

4.0

1.8

—

(3012441) Differential panel - Pleural fluid

343

2012

1.11

1.09

1.5

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

336

1970

1.11

1.08

1.1

1.0

3.63

2.50

u/ml

0.27

457

(3044007) Cell count panel - Peritoneal fluid

111

601

1.20

1.07

2.2

1.9

—

(3022670) pH of Venous cord blood

1.86

1.07

1.0

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

269

1.31

1.06

2.9

2.8

1.09

1.20

mg/l

0.19

173

(3018001) Oat IgE Ab [Units/volume] in Serum

208

1.34

1.03

1.0

0.39

0.78

u/ml

0.34

125

(40758292) HTLV I+II Ab panel - Serum

487

1.22

1.00

1.4

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.76

1.00

1.1

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.89

1.00

2.6

2.3

—

(3020650) Glucose [Presence] in Urine

104

805

0.84

0.98

1.6

1.4

—

(3041184) Isoniazid [Presence] in Urine

1.98

0.96

2.9

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

1.98

0.96

1.0

1.1

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

359

2130

1.10

0.95

1.5

52346.71

45228.44

e6/l

0.22

235

1240

(3026470) Cobalt [Mass/volume] in Blood

183

1352

0.88

0.95

2.0

3.88

3.72

ug/l

0.07

160

1248

(3034092) Cytoplasmic Ig cells/100 cells in Blood

338

1.25

0.95

10.7

4.9

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1758

11894

0.96

0.93

2.0

1.8

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

750

0.84

0.92

1.2

—

(3045788) Cell count panel - Pleural fluid

312

1843

1.10

0.91

1.5

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

179

1.34

0.91

1.2

1.1

10.02

10.05

mg/l

0.01

163

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

1.60

0.91

1.1

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.60

0.91

1.0

0.07

0.20

u/ml

0.35

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

113

1.44

0.90

1.1

1.0

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

370

1.23

0.89

1.0

—

(3038205) Alternaria alternata IgE Ab [Units/volume] in Serum

1.53

0.89

1.1

1.0

0.13

0.20

u/ml

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.54

0.88

1.3

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

406

2433

1.09

0.88

1.4

1.3

184.24

189.86

pmol/l

0.08

406

2433

(3015076) Soybean IgE Ab [Units/volume] in Serum

304

1799

1.10

0.87

1.1

1.0

0.68

0.63

u/ml

0.07

105

391

(3047189) Immunofixation for 24 hour Urine

176

1012

1.13

0.85

2.1

1.9

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.66

0.84

1.1

1.0

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.79

0.84

1.1

1.0

—

(3010937) Rubella virus Ab [Presence] in Serum

188

1.31

0.83

1.1

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.73

0.81

1.1

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.73

0.81

1.5

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

178

1.32

0.80

1.0

—

(40765096) Chromosome analysis panel by Banding

120

676

1.15

0.79

1.1

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

520

1.18

0.78

2.6

2.5

—

(3025577) Chromium [Mass/volume] in Blood

180

1309

0.89

0.77

2.1

2.52

2.44

ug/l

0.06

145

1102

(3042010) Triglyceride [Moles/volume] in Pleural fluid

307

1.23

0.76

1.3

1.90

1.55

mmol/l

0.15

195

(3000690) Aldosterone [Moles/time] in 24 hour Urine

2.17

0.76

1.2

1.1

30.58

31.25

nmol/24h

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

1.49

0.75

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

141

1.34

0.73

1.1

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1.63

0.73

1.0

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.71

0.73

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

147

1.33

0.72

1.4

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

369

1.20

0.72

1.4

1.3

—

(3011325) HIV 1+2 Ab [Presence] in Serum

136

1.34

0.71

1.1

1.0

—

(3015183) Erythrocyte sedimentation rate

268

1597

1.09

0.71

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

540

1.16

0.68

1.1

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

1.67

0.67

1.0

1.1

75.33

69.69

—

(3051101) Glucose [Moles/volume] in Cord blood

389

0.82

0.67

4.6

5.5

—

(3022689) Creatine [Moles/volume] in Urine

125

717

1.13

0.67

1.4

1.5

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

172

1.29

0.67

6.0

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

236

1.24

0.67

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

386

0.83

0.63

1.7

1.2

6.49

7.09

mmol/l

0.57

116

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

298

1.20

0.61

1.1

1.5

—

(21494434) Karyotype in Bone marrow

327

1987

1.07

0.57

1.2

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

1.70

0.57

1.2

1.0

—

(3023383) Lactate [Moles/volume] in Pleural fluid

102

586

1.13

0.57

1.3

3.52

3.24

mmol/l

0.43

546

(3032868) Hemoglobin electrophoresis panel in Blood

272

1.20

0.55

1.6

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

414

2853

0.94

0.55

1.6

7.87

7.58

mmol/l

2.06

399

2735

(3029396) Erythrocyte agglutination [Presence] in Blood

168

997

1.10

0.54

2.7

3.0

—

(40763590) HLA-DQ beta [Type]

104

1.31

0.51

1.0

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

133

1.27

0.50

2.0

1.9

18.42

17.79

0.03

(40760409) HLA-A [Type] by High resolution

105

1.30

0.48

1.0

—

(40760410) HLA-B [Type] by High resolution

105

1.30

0.48

1.0

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

182

0.79

0.48

1.1

1.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

1.41

0.47

1.0

1.1

6.45

7.08

kpa

0.53

(3018291) Platelet Ab [Presence] in Serum

1.46

0.47

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

578

1.11

0.46

1.3

1.4

2.92

2.50

0.20

484

(46236302) HLA-C [Type] by High resolution typing

106

1.29

0.46

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

177

1.21

0.44

1.1

6.67

17.41

iu/ml

—

(3006598) pH of Arterial cord blood

1.39

0.44

1.0

1.1

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

231

1406

1.07

0.43

1.3

12.91

13.88

u/l

0.40

211

1293

(3013862) HLA-DP [Type]

107

1.28

0.43

1.0

—

(3009992) Blasts/100 cells in Bone marrow

1.55

0.42

1.4

2.0

24.60

14.38

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.39

0.42

2.3

2.1

—

(3035880) pH of Pleural fluid

177

1070

1.08

0.41

1.3

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

173

1.20

0.41

2.0

1.9

41.88

61.14

1.68

111

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

268

1644

1.06

0.41

1.4

5.75

5.52

mmol/l

1.76

251

1555

(3045759) Histamine [Moles/volume] in Serum or Plasma

1.48

0.40

1.6

1.5

—

(3003157) Bacteria [#/volume] in Mother's milk

0.66

0.40

6.3

6.8

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

295

1.15

0.39

1.3

1.4

8.33

12.83

0.94

150

(3041918) Cholesterol [Moles/volume] in Pleural fluid

381

1.13

0.39

1.2

1.74

1.81

mmol/l

0.18

226

(40768806) Pleura Pathology biopsy report

330

2041

1.05

0.38

1.5

1.6

—

(3046861) Legionella sp Ag [Presence] in Urine

127

1.23

0.38

1.3

1.1

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

104

0.75

0.38

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2817

18028

1.02

0.38

1.4

1.5

—

(3017958) Strawberry IgE Ab [Units/volume] in Serum

1.27

0.37

1.0

0.03

0.17

u/ml

0.82

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

125

0.78

0.36

1.0

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

2627

17362

0.98

0.36

1.7

1.6

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.30

0.34

1.0

1.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

147

1.19

0.34

1.0

1.1

0.23

10.35

u/ml

0.51

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

392

1.11

0.33

1.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

106

636

1.08

0.32

1.3

40.68

40.88

0.02

436

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

543

1.09

0.32

2.1

1.7

1.56

3.81

ug/l

1.49

331

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

462

1.10

0.32

1.4

25.56

23.45

0.24

388

(3034614) HLA Ag [Interpretation]

1.30

0.32

1.8

1.2

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.34

0.31

1.0

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

568

3583

1.03

0.29

3.3

3.1

0.78

0.80

nmol/l

0.56

420

2798

(3048879) Bone marrow aspiration report

107

647

1.08

0.29

2.1

1.9

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

673

4262

1.03

0.27

1.4

1.3

7.09

6.97

mmol/l

0.53

612

3779

(3007542) Rye IgE Ab [Units/volume] in Serum

163

1.16

0.27

1.0

1.1

0.61

12.37

u/ml

0.48

(43055442) Apixaban [Mass/volume] in Serum or Plasma

277

0.89

0.25

1.6

1.5

112.89

121.90

ug/l

0.19

223

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

405

0.92

0.24

6.3

7.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

1.30

0.23

1.2

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

327

1.09

0.23

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

129

1.16

0.23

1.1

1.0

—

(3011544) Albumin [Mass/volume] in Pleural fluid

172

1.13

0.23

1.1

1.2

19.02

17.72

g/l

0.46

154

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

265

1.10

0.23

1.3

32.03

325.85

u/l

1.01

189

(3038071) Oxygen [Partial pressure] in Mixed venous blood

544

0.93

0.22

7.6

8.3

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.22

0.0

5.7

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.22

0.0

1.1

—

(3025311) HLA-B [Type]

0.00

0.22

0.0

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.22

0.0

1.1

—

2.13

—

(4281824) Cell count and differential, peritoneal fluid

455

2882

1.03

0.21

1.2

1.1

—

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.21

0.0

1.4

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

112

1.16

0.20

1.1

1.0

0.12

0.48

u/ml

0.91

(40758358) Immune stain study

113

1.15

0.19

1.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

327

2067

1.03

0.19

1.0

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

1.21

0.17

1.1

1.2

19.87

30.80

mg/l

1.91

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

617

0.95

0.17

7.7

8.5

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.23

0.17

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

403

1.07

0.17

3.1

2.7

3066.98

1773.98

u/l

0.56

364

(3009015) Lactate [Moles/volume] in Synovial fluid

252

1.08

0.16

1.2

1.3

5.52

6.39

mmol/l

0.50

123

(40762814) Titanium [Mass/volume] in Blood

382

0.94

0.15

2.1

2.3

4.33

4.00

ug/l

0.09

133

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

654

0.95

0.15

1.4

1.3

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

361

1.06

0.14

8.4

8.6

0.37

0.40

umol/l

0.17

332

(3051387) C reactive protein [Mass/volume] in Capillary blood

861

5527

1.01

0.13

4.2

3.0

22.16

26.16

mg/l

2.52

531

3450

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

145

0.90

0.13

1.0

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

684

4508

0.99

0.12

1.2

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.13

0.12

1.1

1.0

—

(3045142) Bone marrow Pathology biopsy report

420

2686

1.02

0.11

1.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

359

1.05

0.11

3.2

3.0

—

(3014891) Appearance of Pleural fluid

232

1.07

0.10

1.6

1.2

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

1.15

0.10

1.4

1.2

4.44

5.82

mg/l

0.12

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

1.05

0.08

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

1.03

0.08

1.0

1.1

603.33

2314.21

titre

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

197

1.06

0.07

4.9

2.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

305

1957

1.01

0.07

1.3

1.2

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.02

0.07

1.0

1.1

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

243

0.96

0.04

1.3

1.4

69.52

72.36

0.20

205

(3044336) Cobalt [Moles/volume] in Urine

0.93

0.02

3.6

2.4

37.45

26.42

nmol/l

—

(3008607) Semen analysis panel

261

1.02

0.02

1.3

1.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

1.07

0.01

5.2

5.4

0.17

0.23

mmol/l

0.65

(3035611) Eosinophils/100 leukocytes in Synovial fluid

154

0.97

0.01

1.7

1.8

1.32

0.47

0.58

118

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

113

1.04

0.00

1.0

1.1

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

121

0.97

0.00

1.0

0.14

0.23

u/ml

0.31

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

114

1.03

0.00

11.4

12.9

—

(3003577) Lead [Moles/volume] in Blood

230

0.99

0.00

1.2

1.5

0.19

0.21

umol/l

0.11

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

101

0.97

0.00

1.0

0.19

1.03

u/ml

—

(3001729) Color of Synovial fluid

187

1.01

0.00

1.6

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

138

0.99

0.00

1.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

133

1.03

0.00

1.1

—

(4212803) Bone marrow aspirate examination

199

1.01

0.00

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

494

1.00

0.00

1.2

1.3

57.73

222.56

ug/l

2.69

260

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.99

-0.00

1.2

1.1

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.93

-0.00

1.2

1.0

—

(3037820) Gliadin IgA Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.90

-0.00

1.4

1.3

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.90

-0.00

1.4

1.3

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.95

-0.00

1.0

—

(3006706) IgM [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.8

—

5.63

—

Mortality – FinRegistry

↥

Association

Association between endpoint KRA_PSY_ANXIETY_EXMORE and mortality.

Females

Parameter	HR [95% CI]	p-value
KRA_PSY_ANXIETY_EXMORE	1.89 [1.7, 2.09]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.01

During the follow-up period (1.1.1998 — 31.12.2019), 18891 out of 236874 females with KRA_PSY_ANXIETY_EXMORE died.

Males

Parameter	HR [95% CI]	p-value
KRA_PSY_ANXIETY_EXMORE	2.194 [1.99, 2.42]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 15452 out of 142433 males with KRA_PSY_ANXIETY_EXMORE died.

Mortality risk

Mortality risk for people of age

years, who have KRA_PSY_ANXIETY_EXMORE.

N-year risk	Females	Males
1	0.16%	0.351%
5	0.819%	2.365%
10	2.079%	6.204%
15	4.01%	11.899%
20	7.188%	19.14%

Relationships between endpoints

↥

Index endpoint: KRA_PSY_ANXIETY_EXMORE – Anxiety disorders, excluding more controls

GWS hits: 31

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Anxiety disorders, excluding more controls

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints